Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in Eur J Heart Fail

Retrieve available abstracts of 640 articles:
HTML format
Text format



Single Articles


    August 2018
  1. GRAZIANI F, Varone F, Crea F, Richeldi L, et al
    Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis.
    Eur J Heart Fail. 2018 Aug 7. doi: 10.1002/ejhf.1286.
    PubMed     Text format     Abstract available


  2. GAGLIARDI C, Perfetto F, Lorenzini M, Ferlini A, et al
    Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.
    Eur J Heart Fail. 2018 Aug 2. doi: 10.1002/ejhf.1285.
    PubMed     Text format     Abstract available


  3. VAN WOERDEN G, Gorter TM, Daan Westenbrink B, Willems TP, et al
    Epicardial fat in heart failure patients with mid-range and preserved ejection fraction.
    Eur J Heart Fail. 2018 Aug 1. doi: 10.1002/ejhf.1283.
    PubMed     Text format     Abstract available


    July 2018
  4. MAGINI A, Farina S, Riggio D, Sandri MT, et al
    ST2 and B-type natriuretic peptide kinetics during exercise in severe heart failure.
    Eur J Heart Fail. 2018 Jul 27. doi: 10.1002/ejhf.1246.
    PubMed     Text format    


  5. COTTER G, Davison BA
    Unmodifiable events, heart failure research, and 'risk-based monitoring' in large studies-the unholy triumvirate.
    Eur J Heart Fail. 2018 Jul 27. doi: 10.1002/ejhf.1282.
    PubMed     Text format    


  6. SCHMITTO JD, Pya Y, Zimpfer D, Krabatsch T, et al
    Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.
    Eur J Heart Fail. 2018 Jul 27. doi: 10.1002/ejhf.1284.
    PubMed     Text format     Abstract available


  7. DOEHNER W, Celutkiene J, Haeusler KG
    Central command in heart failure: was there effect of hemispheric lateralization in insular cortex activation? Reply.
    Eur J Heart Fail. 2018 Jul 13. doi: 10.1002/ejhf.1281.
    PubMed     Text format    


  8. CARBONE S, Elagizi A, Lavie CJ
    Obesity and mortality risk in heart failure: when adipose tissue distribution matters.
    Eur J Heart Fail. 2018 Jul 12. doi: 10.1002/ejhf.1279.
    PubMed     Text format    


  9. MAHMOOD SS, Patel RB, Butler J, Vaduganathan M, et al
    Epirubicin and long-term heart failure risk in breast cancer survivors.
    Eur J Heart Fail. 2018 Jul 4. doi: 10.1002/ejhf.1215.
    PubMed     Text format    


  10. STRENG KW, Voors AA, Hillege HL, Anker SD, et al
    Waist-to-hip ratio and mortality in heart failure.
    Eur J Heart Fail. 2018 Jul 2. doi: 10.1002/ejhf.1244.
    PubMed     Text format     Abstract available


  11. JAARSMA T, van der Wal M, Hjelmfors L, Stromberg A, et al
    Talking about palliative care in heart failure.
    Eur J Heart Fail. 2018 Jul 2. doi: 10.1002/ejhf.1239.
    PubMed     Text format    


  12. PATEL KV, Pandey A
    Prognostic implications of microvascular complications in patients with diabetes and heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2018 Jul 2. doi: 10.1002/ejhf.1253.
    PubMed     Text format    


  13. METRA M
    July 2018 at a glance: practical guidance in acute heart failure, pathophysiology and clinical trials of medical therapy.
    Eur J Heart Fail. 2018;20:1079-1080.
    PubMed     Text format    


    June 2018
  14. CAMPBELL RT, Petrie MC, Jackson CE, Jhund PS, et al
    Which patients with heart failure should receive specialist palliative care?
    Eur J Heart Fail. 2018 Jun 28. doi: 10.1002/ejhf.1240.
    PubMed     Text format     Abstract available


  15. COOPER LB, Yap J, Tay WT, Teng TK, et al
    Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registry.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1223.
    PubMed     Text format     Abstract available


  16. ANKER MS, von Haehling S, Landmesser U, Coats AJS, et al
    Cancer and heart failure-more than meets the eye: common risk factors and co-morbidities.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1252.
    PubMed     Text format    


  17. CUTHBERT JJ, Pellicori P, Rigby A, Pan D, et al
    Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1247.
    PubMed     Text format     Abstract available


  18. SIMONOVIC D, Coiro S, Carluccio E, Girerd N, et al
    Exercise elicits dynamic changes in extravascular lung water and haemodynamic congestion in heart failure patients with preserved ejection fraction.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1228.
    PubMed     Text format    


  19. PASCUAL-FIGAL D, Bayes-Genis A
    The misperception of 'stable' heart failure.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1248.
    PubMed     Text format    


  20. PATEL RB, Vaduganathan M, Greene SJ, Butler J, et al
    Nomenclature in heart failure: a call for objective, reproducible, and biologically-driven terminology.
    Eur J Heart Fail. 2018 Jun 26. doi: 10.1002/ejhf.1231.
    PubMed     Text format    


  21. VACCARO O, Riccardi G, Maggioni AP
    Risk of heart failure in diabetic patients receiving sulfonylureas.
    Eur J Heart Fail. 2018 Jun 22. doi: 10.1002/ejhf.1238.
    PubMed     Text format    


  22. AMBROSY AP, Chioncel O
    Combination drug therapy in heart failure: greater than the sum of its parts.
    Eur J Heart Fail. 2018 Jun 22. doi: 10.1002/ejhf.1251.
    PubMed     Text format    


  23. KREMER D, Ter Maaten JM, Voors AA
    Bio-adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure.
    Eur J Heart Fail. 2018 Jun 22. doi: 10.1002/ejhf.1245.
    PubMed     Text format    


  24. OBOKATA M, Borlaug BA
    The strengths and limitations of E/e' in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2018 Jun 22. doi: 10.1002/ejhf.1250.
    PubMed     Text format    


  25. IORIO A, Senni M, Barbati G, Greene SJ, et al
    Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Eur J Heart Fail. 2018 Jun 19. doi: 10.1002/ejhf.1202.
    PubMed     Text format     Abstract available


  26. WOLSK E
    Heart failure and co-morbidity revisited; the elephant in the room.
    Eur J Heart Fail. 2018 Jun 19. doi: 10.1002/ejhf.1225.
    PubMed     Text format    


  27. GRODIN JL, Testani JM, Pandey A, Sambandam K, et al
    Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT.
    Eur J Heart Fail. 2018 Jun 12. doi: 10.1002/ejhf.1229.
    PubMed     Text format     Abstract available


  28. SOKORELI I, Pauws SC, Riistama JM, Cleland JG, et al
    Psychosocial factors and mortality in patients with heart failure: reply.
    Eur J Heart Fail. 2018 Jun 12. doi: 10.1002/ejhf.1224.
    PubMed     Text format    


  29. NAGAI M, Dote K, Kato M
    Central command in heart failure: was there effect of hemispheric lateralization in insular cortex activation?
    Eur J Heart Fail. 2018 Jun 11. doi: 10.1002/ejhf.1233.
    PubMed     Text format    


  30. PACKER M
    Risk of heart failure in diabetic patients receiving sulfonylureas: reply.
    Eur J Heart Fail. 2018 Jun 11. doi: 10.1002/ejhf.1232.
    PubMed     Text format    


  31. BUTLER J, Vijayakumar S, Pitt B
    Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonists.
    Eur J Heart Fail. 2018 Jun 8. doi: 10.1002/ejhf.1217.
    PubMed     Text format    


  32. NAUTA JF, Hummel YM, van der Meer P, Lam CSP, et al
    Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patient
    Eur J Heart Fail. 2018 Jun 7. doi: 10.1002/ejhf.1220.
    PubMed     Text format     Abstract available


  33. METRA M
    June 2018 at a glance: peripartum cardiomyopathy and pathophysiology, prognosis, and device therapy of heart failure.
    Eur J Heart Fail. 2018;20:949-950.
    PubMed     Text format    


    May 2018
  34. KONSTAM MA
    Seeking therapeutic precision in heart failure: is ejection fraction really the way? Deconstructing the CHARM of heart failure with mid-range ejection fraction.
    Eur J Heart Fail. 2018 May 31. doi: 10.1002/ejhf.1205.
    PubMed     Text format    


  35. ROSSIGNOL P, Ferreira JP, Zannad F
    Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settings.
    Eur J Heart Fail. 2018 May 31. doi: 10.1002/ejhf.1214.
    PubMed     Text format    


  36. GREENBERG B
    Mineralocorticoid receptor antagonists in heart failure: they work better when patients use them.
    Eur J Heart Fail. 2018 May 31. doi: 10.1002/ejhf.1222.
    PubMed     Text format    


  37. LAUFS U, Griese-Mammen N, Krueger K, Wachter A, et al
    PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study.
    Eur J Heart Fail. 2018 May 30. doi: 10.1002/ejhf.1213.
    PubMed     Text format     Abstract available


  38. NAGAI T, Sundaram V, Shoaib A, Shiraishi Y, et al
    Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan.
    Eur J Heart Fail. 2018 May 30. doi: 10.1002/ejhf.1210.
    PubMed     Text format     Abstract available


  39. KOMAJDA M, Bohm M, Borer JS, Ford I, et al
    Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis.
    Eur J Heart Fail. 2018 May 27. doi: 10.1002/ejhf.1234.
    PubMed     Text format     Abstract available


  40. CRESPO-LEIRO MG, Metra M, Lund LH, Milicic D, et al
    Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2018 May 27. doi: 10.1002/ejhf.1236.
    PubMed     Text format     Abstract available


  41. SHARMA A, Al-Khatib SM, Ezekowitz JA, Cooper LB, et al
    Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
    Eur J Heart Fail. 2018 May 15. doi: 10.1002/ejhf.1192.
    PubMed     Text format     Abstract available


  42. KRISTENSEN SL, Rorth R, Jhund PS, Shen L, et al
    Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial.
    Eur J Heart Fail. 2018 May 4. doi: 10.1002/ejhf.1201.
    PubMed     Text format     Abstract available


  43. KORATALA A
    Metabolic abnormalities in heart failure patients treated with ultrafiltration versus diuretics.
    Eur J Heart Fail. 2018 May 3. doi: 10.1002/ejhf.1207.
    PubMed     Text format    



  44. Abstracts of the Heart Failure 2018 and the World Congress on Acute Heart Failure, 26-29 May 2018, Vienna, Austria.
    Eur J Heart Fail. 2018;20 Suppl 1:5-638.
    PubMed     Text format    


    April 2018
  45. HARJOLA VP, Parissis J, Brunner-La Rocca HP, Celutkiene J, et al
    Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Ca
    Eur J Heart Fail. 2018 Apr 30. doi: 10.1002/ejhf.1204.
    PubMed     Text format     Abstract available


  46. RAVASSA S, Trippel T, Bach D, Bachran D, et al
    Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
    Eur J Heart Fail. 2018 Apr 30. doi: 10.1002/ejhf.1194.
    PubMed     Text format     Abstract available


  47. KAWADA T
    Psychosocial factors and mortality in patients with heart failure.
    Eur J Heart Fail. 2018 Apr 24. doi: 10.1002/ejhf.1208.
    PubMed     Text format    


  48. VAN VELDHUISEN DJ, Rienstra M, van der Meer P
    Value of digoxin in patients with heart failure: new pieces to the puzzle.
    Eur J Heart Fail. 2018 Apr 20. doi: 10.1002/ejhf.1200.
    PubMed     Text format    


  49. CERLINSKAITE K, Hollinger A, Mebazaa A, Cinotti R, et al
    Finding the balance between costs and quality in heart failure: a global challenge.
    Eur J Heart Fail. 2018 Apr 19. doi: 10.1002/ejhf.1195.
    PubMed     Text format    


  50. ALLA F, Agrinier N, Lavielle M, Rossignol P, et al
    Impact of the interruption of a large heart failure regional disease management programme on hospital admission rates: a population-based study.
    Eur J Heart Fail. 2018 Apr 16. doi: 10.1002/ejhf.1193.
    PubMed     Text format    


  51. DOEHNER W, Ural D, Celutkiene J
    Heart-brain interactions in patients with heart failure, including takotsubo syndrome: a need to monitor autonomic sympathetic activity: reply.
    Eur J Heart Fail. 2018 Apr 14. doi: 10.1002/ejhf.1177.
    PubMed     Text format    


  52. KLEBER FX, Koln PJ
    Oxygen consumption trajectory flattening-yet another cardiopulmonary exercise testing parameter in chronic heart failure.
    Eur J Heart Fail. 2018 Apr 14. doi: 10.1002/ejhf.1181.
    PubMed     Text format    


  53. GRODIN JL, Tang WHW
    I will take my heart failure 'lactate-free' please.
    Eur J Heart Fail. 2018 Apr 10. doi: 10.1002/ejhf.1190.
    PubMed     Text format    


    March 2018
  54. PACKER M
    Augmentation of glucagon-like peptide-1 receptor signalling by neprilysin inhibition: potential implications for patients with heart failure.
    Eur J Heart Fail. 2018 Mar 30. doi: 10.1002/ejhf.1185.
    PubMed     Text format     Abstract available


  55. FUDIM M, Mentz RJ
    Early versus late readmission during the vulnerable phase following hospitalization for heart failure: reply.
    Eur J Heart Fail. 2018 Mar 30. doi: 10.1002/ejhf.1189.
    PubMed     Text format    


  56. KIMURA M, Kohno T, Yoshikawa T
    Early versus late readmission during the vulnerable phase following hospitalization for heart failure.
    Eur J Heart Fail. 2018 Mar 30. doi: 10.1002/ejhf.1179.
    PubMed     Text format    


  57. SLIWA K, Petrie MC, Hilfiker-Kleiner D, Mebazaa A, et al
    Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy.
    Eur J Heart Fail. 2018 Mar 26. doi: 10.1002/ejhf.1178.
    PubMed     Text format     Abstract available


  58. SAVARESE G, Carrero JJ, Pitt B, Anker SD, et al
    Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry.
    Eur J Heart Fail. 2018 Mar 26. doi: 10.1002/ejhf.1182.
    PubMed     Text format     Abstract available


  59. PACKER M
    Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medications.
    Eur J Heart Fail. 2018 Mar 22. doi: 10.1002/ejhf.1183.
    PubMed     Text format     Abstract available


  60. MAGKOUTIS N, Mantzaraki V, Farmakis D, Spathis A, et al
    Effects of functional electrical stimulation of lower limb muscles on circulating endothelial progenitor cells, CD34+ cells and vascular endothelial growth factor-A in heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2018 Mar 14. doi: 10.1002/ejhf.1176.
    PubMed     Text format    


  61. SEFEROVIC PM, Petrie MC, Filippatos GS, Anker SD, et al
    Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2018 Mar 8. doi: 10.1002/ejhf.1170.
    PubMed     Text format     Abstract available


  62. FERRARI R, Bueno H, Chioncel O, Cleland JG, et al
    Acute heart failure: lessons learned, roads ahead.
    Eur J Heart Fail. 2018 Mar 8. doi: 10.1002/ejhf.1169.
    PubMed     Text format    


  63. AVOGARO A, Fadini GP
    Insulin treatment in patients with diabetes and heart failure: defendant on the stand.
    Eur J Heart Fail. 2018 Mar 8. doi: 10.1002/ejhf.1161.
    PubMed     Text format    


  64. DEMISSEI BG, Voors AA
    Risk stratification in acute heart failure: reply.
    Eur J Heart Fail. 2018 Mar 7. doi: 10.1002/ejhf.1171.
    PubMed     Text format    


  65. SILISTE RN, Antohi EL, Pepoyan S, Nakou E, et al
    Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice.
    Eur J Heart Fail. 2018 Mar 5. doi: 10.1002/ejhf.1153.
    PubMed     Text format     Abstract available


  66. WOLDMAN S
    Heart failure management-time to change our script on prognosis?
    Eur J Heart Fail. 2018 Mar 1. doi: 10.1002/ejhf.1157.
    PubMed     Text format    


  67. PACKER M
    Derangements in adrenergic-adipokine signalling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction.
    Eur J Heart Fail. 2018 Mar 1. doi: 10.1002/ejhf.1167.
    PubMed     Text format     Abstract available


  68. GRODIN JL, Carter S, Bart BA, Goldsmith SR, et al
    Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF.
    Eur J Heart Fail. 2018 Mar 1. doi: 10.1002/ejhf.1158.
    PubMed     Text format     Abstract available


  69. ABDUL-RAHIM AH, Shen L, Rush CJ, Jhund PS, et al
    Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Eur J Heart Fail. 2018 Mar 1. doi: 10.1002/ejhf.1160.
    PubMed     Text format     Abstract available


  70. LUND LH, Pitt B
    Is hyperkalaemia in heart failure a risk factor or a risk marker? Implications for renin-angiotensin-aldosterone system inhibitor use.
    Eur J Heart Fail. 2018 Mar 1. doi: 10.1002/ejhf.1175.
    PubMed     Text format    


  71. BANKE A, Fosbol EL, Moller JE, Gislason GH, et al
    Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial.
    Eur J Heart Fail. 2018 Mar 1. doi: 10.1002/ejhf.1168.
    PubMed     Text format     Abstract available


    February 2018
  72. COSMI F, Shen L, Magnoli M, Abraham WT, et al
    Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
    Eur J Heart Fail. 2018 Feb 28. doi: 10.1002/ejhf.1146.
    PubMed     Text format     Abstract available


  73. AMERI P, Canepa M, Anker MS, Belenkov Y, et al
    Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge.
    Eur J Heart Fail. 2018 Feb 21. doi: 10.1002/ejhf.1165.
    PubMed     Text format     Abstract available


  74. LINDGREN M, Eriksson P, Rosengren A, Robertson J, et al
    Cognitive performance in late adolescence and long-term risk of early heart failure in Swedish men.
    Eur J Heart Fail. 2018 Feb 19. doi: 10.1002/ejhf.1163.
    PubMed     Text format     Abstract available


  75. MADIAS JE
    Heart-brain interactions in patients with heart failure, including takotsubo syndrome: a need to monitor autonomic sympathetic activity.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1150.
    PubMed     Text format    


  76. LEVY WC, Dardas TF
    Comparison of cardiopulmonary-based risk models with a clinical heart failure risk model.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1164.
    PubMed     Text format    


  77. AKIYAMA E, Van Aelst LNL, Arrigo M, Lassus J, et al
    East Asia may have a better 1-year survival following an acute heart failure episode compared with Europe: results from an international observational cohort.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1152.
    PubMed     Text format    


  78. ZYMLINSKI R, Biegus J, Sokolski M, Siwolowski P, et al
    Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1156.
    PubMed     Text format     Abstract available


  79. LUND LH, Claggett B, Liu J, Lam CS, et al
    Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1149.
    PubMed     Text format     Abstract available


  80. MOGENSEN UM, Gong J, Jhund PS, Shen L, et al
    Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1139.
    PubMed     Text format     Abstract available


  81. COMIN-COLET J, Manito N, Segovia-Cubero J, Delgado J, et al
    Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
    Eur J Heart Fail. 2018 Feb 6. doi: 10.1002/ejhf.1145.
    PubMed     Text format     Abstract available


  82. ORBAN M, Besler C, Braun D, Nabauer M, et al
    Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure.
    Eur J Heart Fail. 2018 Feb 6. doi: 10.1002/ejhf.1147.
    PubMed     Text format     Abstract available


  83. POPOVIC D, Arena R, Guazzi M
    A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction.
    Eur J Heart Fail. 2018 Feb 6. doi: 10.1002/ejhf.1140.
    PubMed     Text format     Abstract available


  84. METRA M
    February 2018 at a glance: heart and brain interaction, prognostic variables, and acute heart failure and post-discharge outcomes.
    Eur J Heart Fail. 2018;20:191-192.
    PubMed     Text format    


    January 2018
  85. TROMP J, Voors AA, Lam CSP
    Heart failure with mid-range ejection fraction: causes and consequences.
    Eur J Heart Fail. 2018 Jan 16. doi: 10.1002/ejhf.1134.
    PubMed     Text format    


  86. TROMP J, van der Meer P
    Predicting heart failure: one size does not fit all.
    Eur J Heart Fail. 2018 Jan 15. doi: 10.1002/ejhf.1120.
    PubMed     Text format    


  87. LUND LH, Vedin O, Savarese G
    Is ejection fraction in heart failure a limitation or an opportunity?
    Eur J Heart Fail. 2018 Jan 15. doi: 10.1002/ejhf.1106.
    PubMed     Text format    


  88. COSTANZO MR
    Uric acid is important, but there is something that matters even more: to deliver sacubitril/valsartan to eligible heart failure patients.
    Eur J Heart Fail. 2018 Jan 12. doi: 10.1002/ejhf.1087.
    PubMed     Text format    


  89. ARQUES S
    Myocardial oedema and congestive heart failure: one piece of the puzzle?
    Eur J Heart Fail. 2018 Jan 12. doi: 10.1002/ejhf.1121.
    PubMed     Text format    


  90. BEUSEKAMP JC, Tromp J, van der Wal HH, Anker SD, et al
    Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.
    Eur J Heart Fail. 2018 Jan 12. doi: 10.1002/ejhf.1079.
    PubMed     Text format     Abstract available


  91. GORTER TM, de Boer RA
    Myocardial oedema and congestive heart failure: one piece of the puzzle? Reply.
    Eur J Heart Fail. 2018 Jan 10. doi: 10.1002/ejhf.1136.
    PubMed     Text format    


  92. DONAL E, Galli E
    Clinical relevance of spectral tissue Doppler-derived E/e' in the diagnosis of heart failure with preserved ejection fraction: reply.
    Eur J Heart Fail. 2018 Jan 8. doi: 10.1002/ejhf.1090.
    PubMed     Text format    


  93. LUND LH
    Complex relationships between co-morbidity, outcomes, and treatment effect in heart failure.
    Eur J Heart Fail. 2018 Jan 5. doi: 10.1002/ejhf.1107.
    PubMed     Text format    


  94. DE ROSA S, Eposito F, Carella C, Strangio A, et al
    Transcoronary concentration gradients of circulating microRNAs in heart failure.
    Eur J Heart Fail. 2018 Jan 4. doi: 10.1002/ejhf.1119.
    PubMed     Text format     Abstract available


  95. MCDONALD K, Troughton R, Dahlstrom U, Dargie H, et al
    Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study.
    Eur J Heart Fail. 2018 Jan 4. doi: 10.1002/ejhf.1053.
    PubMed     Text format     Abstract available


  96. MELE D, Nardozza M, Ferrari R
    Left ventricular ejection fraction and heart failure: an indissoluble marriage?
    Eur J Heart Fail. 2018 Jan 4. doi: 10.1002/ejhf.1071.
    PubMed     Text format    


  97. BREIDTHARDT T, Moreno-Weidmann Z, Uthoff H, Sabti Z, et al
    How accurate is clinical assessment of neck veins in the estimation of central venous pressure in acute heart failure? Insights from a prospective study.
    Eur J Heart Fail. 2018 Jan 4. doi: 10.1002/ejhf.1111.
    PubMed     Text format    


  98. AMBROSY AP, Fudim M, Chioncel O
    Sudden cardiac death following admission for acute heart failure: adding insult to injury.
    Eur J Heart Fail. 2018 Jan 4. doi: 10.1002/ejhf.1109.
    PubMed     Text format    


  99. FERREIRA JP, Duarte K, Pfeffer MA, McMurray JJV, et al
    Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarct
    Eur J Heart Fail. 2018 Jan 4. doi: 10.1002/ejhf.1131.
    PubMed     Text format     Abstract available


  100. SUZUKI H, Matsumoto Y, Ota H, Sugimura K, et al
    Structural brain abnormalities and cardiac dysfunction in patients with chronic heart failure.
    Eur J Heart Fail. 2018 Jan 4. doi: 10.1002/ejhf.1104.
    PubMed     Text format    


  101. SOKORELI I, Pauws SC, Steyerberg EW, de Vries GJ, et al
    Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study.
    Eur J Heart Fail. 2018 Jan 4. doi: 10.1002/ejhf.1112.
    PubMed     Text format     Abstract available


  102. VADUGANATHAN M, Samman Tahhan A, Greene SJ, Okafor M, et al
    Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years.
    Eur J Heart Fail. 2018 Jan 4. doi: 10.1002/ejhf.1130.
    PubMed     Text format    


  103. PACKER M
    Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trial.
    Eur J Heart Fail. 2018;20:49-51.
    PubMed     Text format    


    December 2017
  104. TKACZYSZYN M, Jankowska EA
    Iron deficiency and red cell indices in patients with heart failure: reply.
    Eur J Heart Fail. 2017 Dec 27. doi: 10.1002/ejhf.1092.
    PubMed     Text format    


  105. DOEHNER W, Ural D, Haeusler KG, Celutkiene J, et al
    Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association.
    Eur J Heart Fail. 2017 Dec 27. doi: 10.1002/ejhf.1100.
    PubMed     Text format     Abstract available


  106. ROSANO GMC, Seferovic P, Farmakis D, Filippatos G, et al
    Renin inhibition in heart failure and diabetes: the real story.
    Eur J Heart Fail. 2017 Dec 22. doi: 10.1002/ejhf.1072.
    PubMed     Text format    


  107. XANTHOPOULOS A, Tryposkiadis K, Giamouzis G, Konstantinou D, et al
    Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure.
    Eur J Heart Fail. 2017 Dec 22. doi: 10.1002/ejhf.1132.
    PubMed     Text format    


  108. RAMALHO SHR, Shah AM
    Central sleep apnoea in heart failure with reduced ejection fraction, adaptive servo-ventilation, and left ventricular ejection fraction: the (still) missing link.
    Eur J Heart Fail. 2017 Dec 22. doi: 10.1002/ejhf.1108.
    PubMed     Text format    


  109. POKORNEY SD, Al-Khatib SM, Sun JL, Schulte P, et al
    Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.
    Eur J Heart Fail. 2017 Dec 20. doi: 10.1002/ejhf.1078.
    PubMed     Text format     Abstract available


  110. VAN AELST LNL, Arrigo M, Placido R, Akiyama E, et al
    Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
    Eur J Heart Fail. 2017 Dec 18. doi: 10.1002/ejhf.1050.
    PubMed     Text format     Abstract available


  111. BISTOLA V, Polyzogopoulou E, Ikonomidis I, Parissis J, et al
    Congestion in acute heart failure with reduced vs. preserved left ventricular ejection fraction: differences, similarities and remaining gaps.
    Eur J Heart Fail. 2017 Dec 18. doi: 10.1002/ejhf.1115.
    PubMed     Text format    


  112. EMMENS JE, Jones DJL, Cao TH, Chan DCS, et al
    Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure.
    Eur J Heart Fail. 2017 Dec 18. doi: 10.1002/ejhf.1101.
    PubMed     Text format     Abstract available


  113. LUPON J, Bayes-Genis A
    Left ventricular ejection fraction in heart failure: a clinician's perspective about a dynamic and imperfect parameter, though still convenient and a cornerstone for patient classification and management.
    Eur J Heart Fail. 2017 Dec 18. doi: 10.1002/ejhf.1116.
    PubMed     Text format    


  114. DELLES C, Rankin NJ, Boachie C, McConnachie A, et al
    Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997.
    Eur J Heart Fail. 2017 Dec 11. doi: 10.1002/ejhf.1076.
    PubMed     Text format     Abstract available


  115. BHAMBHANI V, Kizer JR, Lima JAC, van der Harst P, et al
    Predictors and outcomes of heart failure with mid-range ejection fraction.
    Eur J Heart Fail. 2017 Dec 11. doi: 10.1002/ejhf.1091.
    PubMed     Text format     Abstract available


  116. VON HAEHLING S
    Co-morbidities in heart failure beginning to sprout-and no end in sight?
    Eur J Heart Fail. 2017;19:1566-1568.
    PubMed     Text format    


    November 2017
  117. COWIE MR, Woehrle H, Wegscheider K, Vettorazzi E, et al
    Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF.
    Eur J Heart Fail. 2017 Nov 30. doi: 10.1002/ejhf.1048.
    PubMed     Text format     Abstract available


  118. KHERA R, Pandey A
    The heart failure readmission quagmire: taking a deep dive to find solutions.
    Eur J Heart Fail. 2017 Nov 30. doi: 10.1002/ejhf.1082.
    PubMed     Text format    


  119. ARQUES S
    Clinical relevance of spectral tissue Doppler-derived E/e' in the diagnosis of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Nov 30. doi: 10.1002/ejhf.1084.
    PubMed     Text format    


  120. WOLSK E, Claggett B, Kober L, Pocock S, et al
    Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Eur J Heart Fail. 2017 Nov 30. doi: 10.1002/ejhf.1073.
    PubMed     Text format     Abstract available


  121. SENNI M, McMurray JJV, Wachter R, McIntyre HF, et al
    Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study.
    Eur J Heart Fail. 2017 Nov 22. doi: 10.1002/ejhf.1054.
    PubMed     Text format     Abstract available


  122. ROSSING K, Gustafsson F
    Medical and mechanical unloading in advanced heart failure: hope for cardiac recovery?
    Eur J Heart Fail. 2017 Nov 21. doi: 10.1002/ejhf.1081.
    PubMed     Text format    


  123. TAVAZZI L
    It's time to move on from counting co-morbidities to curing them: the case of chronic heart failure-chronic obstructive pulmonary disease co-morbidity.
    Eur J Heart Fail. 2017 Nov 21. doi: 10.1002/ejhf.1083.
    PubMed     Text format    


  124. GREENE SJ, Felker GM
    Considering the duration of heart failure: using the past to predict the future.
    Eur J Heart Fail. 2017 Nov 21. doi: 10.1002/ejhf.1064.
    PubMed     Text format    


  125. FARMAKIS D, Papingiotis G, Parissis J, Filippatos G, et al
    Ups and downs in heart failure: the case of proteomics.
    Eur J Heart Fail. 2017 Nov 21. doi: 10.1002/ejhf.1065.
    PubMed     Text format    


  126. SESSA M, Mascolo A, Mortensen RN, Andersen MP, et al
    Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
    Eur J Heart Fail. 2017 Nov 20. doi: 10.1002/ejhf.1045.
    PubMed     Text format     Abstract available


  127. RORTH R, Fosbol EL, Mogensen UM, Kragholm K, et al
    Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1046.
    PubMed     Text format     Abstract available


  128. GO YY, Sugimoto T, Bulluck H, Acharyya S, et al
    Age and ejection fraction modify the impact of atrial fibrillation on acute heart failure outcomes.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1075.
    PubMed     Text format    


  129. PALAU P, Dominguez E, Nunez J
    Clinical utility of cardiopulmonary exercise testing in patients with heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1066.
    PubMed     Text format    


  130. LOURENCO AP, Leite-Moreira AF, Balligand JL, Bauersachs J, et al
    An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1059.
    PubMed     Text format     Abstract available


  131. SELVARAJ S, Claggett B, Shah SJ, Anand I, et al
    Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1060.
    PubMed     Text format     Abstract available


  132. GHIO S, Crimi G, Temporelli PL, Traversi E, et al
    Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1067.
    PubMed     Text format     Abstract available


  133. ZENG DX
    Iron deficiency and red cell indices in patients with heart failure.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1052.
    PubMed     Text format    


  134. SCHNEIDER D, Flores D, Mueller C
    Risk stratification in acute heart failure.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1057.
    PubMed     Text format    


  135. VADUGANATHAN M, Cheema B, Cleveland E, Sankar K, et al
    Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial.
    Eur J Heart Fail. 2017 Nov 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  136. ARRIGO M, Mebazaa A
    Addressing vulnerability: opening a new door to improved outcomes in acute heart failure.
    Eur J Heart Fail. 2017 Nov 9. doi: 10.1002/ejhf.1063.
    PubMed     Text format    


  137. LAL S, Kotchetkova I, Cao J, Jackson D, et al
    Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease.
    Eur J Heart Fail. 2017 Nov 7. doi: 10.1002/ejhf.1051.
    PubMed     Text format    


  138. CATINO AB, Ferrin P, Wever-Pinzon J, Horne BD, et al
    Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.
    Eur J Heart Fail. 2017 Nov 1. doi: 10.1002/ejhf.1018.
    PubMed     Text format     Abstract available


    October 2017
  139. PACKER M
    Will long-acting glucagon-like peptide-1 analogues recapitulate our agonizing experience with cyclic AMP-dependent positive inotropic agents in heart failure?
    Eur J Heart Fail. 2017 Oct 30. doi: 10.1002/ejhf.1047.
    PubMed     Text format    


  140. CHEEMA B, Ambrosy AP, Kaplan RM, Senni M, et al
    Lessons learned in acute heart failure.
    Eur J Heart Fail. 2017 Oct 29. doi: 10.1002/ejhf.1042.
    PubMed     Text format     Abstract available


  141. FUDIM M, O'Connor CM, Dunning A, Ambrosy AP, et al
    Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.
    Eur J Heart Fail. 2017 Oct 29. doi: 10.1002/ejhf.1020.
    PubMed     Text format     Abstract available


  142. GREENE SJ, Mentz RJ
    Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'?
    Eur J Heart Fail. 2017 Oct 29. doi: 10.1002/ejhf.1024.
    PubMed     Text format    


  143. KELLY JP, DeVore AD
    Can walking patients with heart failure and preserved ejection fraction tell us who should walk also to the catheterization laboratory or just walk home?
    Eur J Heart Fail. 2017 Oct 29. doi: 10.1002/ejhf.1041.
    PubMed     Text format    


  144. BAJAJ NS, Claggett B, Lewis EF, Desai AS, et al
    Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Oct 25. doi: 10.1002/ejhf.1040.
    PubMed     Text format    


  145. NAUTA JF, Hummel YM, van Melle JP, van der Meer P, et al
    What have we learned about heart failure with mid-range ejection fraction one year after its introduction?
    Eur J Heart Fail. 2017 Oct 24. doi: 10.1002/ejhf.1058.
    PubMed     Text format     Abstract available


  146. PANICO C, Condorelli G
    microRNA-132: a new biomarker of heart failure at last?
    Eur J Heart Fail. 2017 Oct 20. doi: 10.1002/ejhf.1044.
    PubMed     Text format    


  147. PACKER M
    Why is the use of digitalis withering? Another reason that we need medical heart failure specialists.
    Eur J Heart Fail. 2017 Oct 19. doi: 10.1002/ejhf.1043.
    PubMed     Text format    


  148. STEWART COATS AJ
    Intravenous ferric carboxymaltose for heart failure with iron deficiency.
    Eur J Heart Fail. 2017 Oct 19. doi: 10.1002/ejhf.1027.
    PubMed     Text format    


  149. ROY B, Woo M, Kumar R
    Cerebral blood flow in central autonomic network: is there any effect of hemispheric lateralization in patients with heart failure? Reply.
    Eur J Heart Fail. 2017 Oct 18. doi: 10.1002/ejhf.1033.
    PubMed     Text format    


  150. GREENE SJ, Butler J, Fonarow GC, Subacius HP, et al
    Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial.
    Eur J Heart Fail. 2017 Oct 17. doi: 10.1002/ejhf.1019.
    PubMed     Text format     Abstract available


  151. DE BUYZERE ML
    Multi-biomarker risk stratification in heart failure: a story of diminished marginal returns after Herculean efforts?
    Eur J Heart Fail. 2017 Oct 17. doi: 10.1002/ejhf.1035.
    PubMed     Text format    


  152. GORTER TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, et al
    Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2017 Oct 16. doi: 10.1002/ejhf.1029.
    PubMed     Text format     Abstract available


  153. MAISANO F, Ruschitzka F
    Mitral interventions in heart failure: time to deliver on the promise.
    Eur J Heart Fail. 2017 Oct 16. doi: 10.1002.
    PubMed     Text format    


  154. MIRO O, Tost J, Gil V, Martin-Sanchez FJ, et al
    The BRONCH-AHF study: effects on short-term outcome of nebulized bronchodilators in emergency department patients diagnosed with acute heart failure.
    Eur J Heart Fail. 2017 Oct 16. doi: 10.1002/ejhf.1028.
    PubMed     Text format    


  155. SHARMA K, Tedford RJ
    Atrial fibrillation in heart failure with preserved ejection fraction: time to address the chicken and the egg.
    Eur J Heart Fail. 2017 Oct 12. doi: 10.1002.
    PubMed     Text format    


  156. BOHM M, Komajda M, Borer JS, Ford I, et al
    Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT.
    Eur J Heart Fail. 2017 Oct 12. doi: 10.1002/ejhf.1021.
    PubMed     Text format     Abstract available


  157. LA ROVERE MT, Maestri R, Robbi E, Caporotondi A, et al
    Daytime periodic breathing during short-term laboratory recordings in heart failure patients: the iceberg tip of central sleep apnoea?
    Eur J Heart Fail. 2017 Oct 12. doi: 10.1002/ejhf.1031.
    PubMed     Text format    


  158. MASSON S, Batkai S, Beermann J, Bar C, et al
    Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Eur J Heart Fail. 2017 Oct 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  159. MORTARA A
    Inotropes and vasopressors in acute heart failure, when the devil dresses as an angel.
    Eur J Heart Fail. 2017 Oct 12. doi: 10.1002/ejhf.1037.
    PubMed     Text format    


  160. GREENBERG B
    Jumping down the rabbit hole: unravelling the right ventricle in heart failure.
    Eur J Heart Fail. 2017 Oct 12. doi: 10.1002.
    PubMed     Text format    


  161. HANBERG JS, Rao VS, Ahmad T, Chunara Z, et al
    Inflammation and cardio-renal interactions in heart failure: a potential role for interleukin-6.
    Eur J Heart Fail. 2017 Oct 11. doi: 10.1002.
    PubMed     Text format    


  162. KAYE DM, Silvestry FE, Gustafsson F, Cleland JG, et al
    Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.
    Eur J Heart Fail. 2017 Oct 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  163. AGOSTONI P, Guazzi M
    Exercise ventilatory inefficiency in heart failure: some fresh news into the roadmap of heart failure with preserved ejection fraction phenotyping.
    Eur J Heart Fail. 2017 Oct 9. doi: 10.1002.
    PubMed     Text format    


  164. MEBAZAA A, Motiejunaite J, Gayat E, Crespo-Leiro MG, et al
    Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2017 Oct 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  165. VAN ITERSON EH, Johnson BD, Borlaug BA, Olson TP, et al
    Physiological dead space and arterial carbon dioxide contributions to exercise ventilatory inefficiency in patients with reduced or preserved ejection fraction heart failure.
    Eur J Heart Fail. 2017 Oct 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  166. NUNEZ J, Sanchis J, Bayes-Genis A
    Iron status measurement in routine heart failure assessment: a call for action.
    Eur J Heart Fail. 2017 Oct 8. doi: 10.1002.
    PubMed     Text format    


  167. HUMMEL YM, Liu LCY, Lam CSP, Fonseca-Munoz DF, et al
    Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements.
    Eur J Heart Fail. 2017 Oct 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  168. SAVARESE G, Lund LH
    Up-titrating angiotensin-converting enzyme inhibitors in heart failure: evidence and challenges.
    Eur J Heart Fail. 2017 Oct 5. doi: 10.1002.
    PubMed     Text format    


  169. LAM PH, Dooley DJ, Fonarow GC, Butler J, et al
    Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
    Eur J Heart Fail. 2017 Oct 5. doi: 10.1002.
    PubMed     Text format     Abstract available


  170. STENEMO M, Nowak C, Byberg L, Sundstrom J, et al
    Circulating proteins as predictors of incident heart failure in the elderly.
    Eur J Heart Fail. 2017 Oct 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  171. METRA M
    October 2017 at a glance: phenotyping heart failure, co-morbidities, use of evidence-based therapy and new treatments.
    Eur J Heart Fail. 2017;19:1216-1217.
    PubMed     Text format    


  172. TAVAZZI L
    A brief overview of cardiac resynchronization therapy and its current use in clinical practice.
    Eur J Heart Fail. 2017;19:1280-1283.
    PubMed     Text format    


  173. CHEEMA BS, Sabbah HN, Greene SJ, Gheorghiade M, et al
    Protein turnover in the failing heart: an ever-changing landscape.
    Eur J Heart Fail. 2017;19:1218-1221.
    PubMed     Text format    


  174. SOMMER A, Kronborg MB, Nielsen JC
    Guided left ventricular lead placement for cardiac resynchronization therapy - an opportunity for image integration: reply.
    Eur J Heart Fail. 2017;19:1344.
    PubMed     Text format    


    September 2017
  175. MOTIEJUNAITE J, Celutkiene J, Mebazaa A
    The right ventricle drives the progression of heart failure.
    Eur J Heart Fail. 2017 Sep 29. doi: 10.1002.
    PubMed     Text format    


  176. WELSH P, Kou L, Yu C, Anand I, et al
    Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.
    Eur J Heart Fail. 2017 Sep 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  177. LUND LH, Trochu JN, Meyns B, Caliskan K, et al
    Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE-HF) study.
    Eur J Heart Fail. 2017 Sep 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  178. LUPON J, Simpson J, McMurray JJV, de Antonio M, et al
    Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format    


  179. AGOSTONI P, Paolillo S, Mapelli M, Gentile P, et al
    Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  180. LUND LH, Svennblad B, Dahlstrom U, Stahlberg M, et al
    Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  181. VAN BILSEN M, Patel HC, Bauersachs J, Bohm M, et al
    The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  182. CANEPA M, Straburzynska-Migaj E, Drozdz J, Fernandez-Vivancos C, et al
    Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  183. BAYES-GENIS A, Lanfear DE, de Ronde MWJ, Lupon J, et al
    Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  184. HAWKINS NM
    Chronic obstructive pulmonary disease and heart failure in Europe-further evidence of the need for integrated care.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format    


  185. WOLSK E, Kaye D, Borlaug BA, Burkhoff D, et al
    Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  186. VINEREANU D, Margulescu AD
    The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction: reply.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    


  187. VAN BOVEN N, Kardys I, van Vark LC, Akkerhuis KM, et al
    Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  188. KOH AS, Tay WT, Teng THK, Vedin O, et al
    A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  189. BAYES-GENIS A, Nunez J, Lupon J
    Heart failure with mid-range ejection fraction: a transition phenotype?
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    


  190. SANDERSON JE, Fang F, Wei YX
    The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    


  191. WONG LL, Richards AM
    Harnessing the power of microRNAs as prognostic biomarkers in acute heart failure.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    


  192. TOMPKINS BA, Rieger AC, Florea V, Banerjee MN, et al
    New insights into cell-based therapy for heart failure from the CHART-1 study.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    


  193. KRISTENSEN SL, Mogensen UM, Tarnesby G, Gimpelewicz CR, et al
    Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  194. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Limited contractile reserve contributes to poor peak exercise capacity in iron-deficient heart failure.
    Eur J Heart Fail. 2017 Sep 18. doi: 10.1002.
    PubMed     Text format    


  195. CORRA U, Agostoni PG, Anker SD, Coats AJS, et al
    Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2017 Sep 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  196. SQUIRE IB
    Biomarkers and prognostication in heart failure with reduced and preserved ejection fraction: similar but different?
    Eur J Heart Fail. 2017 Sep 18. doi: 10.1002.
    PubMed     Text format    


  197. BUTLER J, Stockbridge N, Gheorghiade M
    Past, present, and future of acute heart failure clinical trials-a high-risk population in search of a strategy.
    Eur J Heart Fail. 2017 Sep 18. doi: 10.1002.
    PubMed     Text format    


  198. NAGAI M, Dote K, Masaya M
    Cerebral blood flow in the central autonomic network: is there any effect of hemispheric lateralization in patients with heart failure?
    Eur J Heart Fail. 2017 Sep 18. doi: 10.1002.
    PubMed     Text format    


  199. GIRERD N, Rossignol P
    Performing lung ultrasound at rest and/or after an exercise stress test to better identify high-risk ambulatory patients with heart failure.
    Eur J Heart Fail. 2017 Sep 18. doi: 10.1002.
    PubMed     Text format    


  200. RAPEZZI C, Milandri A, Lorenzini M
    The complex interplay between systolic and diastolic function at rest and during exercise in heart failure: the case of cardiac amyloidosis.
    Eur J Heart Fail. 2017 Sep 14. doi: 10.1002.
    PubMed     Text format    


  201. PATEL JN, Shah SJ
    Inorganic vs. organic nitrates for heart failure with preserved ejection fraction: it's not all in your head!
    Eur J Heart Fail. 2017 Sep 11. doi: 10.1002.
    PubMed     Text format    


  202. TRIPPEL TD, Van Linthout S, Westermann D, Lindhorst R, et al
    Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide vs. furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Eur J Heart Fail. 2017 Sep 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  203. KALOGEROPOULOS AP, Butler J
    Heart rate in heart failure with preserved ejection fraction: target or marker?
    Eur J Heart Fail. 2017 Sep 11. doi: 10.1002.
    PubMed     Text format    


  204. ZHANG Y, Bauersachs J, Langer HF
    Immune mechanisms in heart failure.
    Eur J Heart Fail. 2017 Sep 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  205. STEWART S
    Home is where the heart is when it comes to transitional care in heart failure, but is it the only way to improve health outcomes?
    Eur J Heart Fail. 2017 Sep 10. doi: 10.1002.
    PubMed     Text format    


  206. PACKER M
    How have millions of people with heart failure benefited from our research over the last 10-15 years? The sounds of dead silence.
    Eur J Heart Fail. 2017 Sep 10. doi: 10.1002.
    PubMed     Text format    


  207. BOSCH L, Carluccio E, Coiro S, Gong L, et al
    Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score.
    Eur J Heart Fail. 2017 Sep 7. doi: 10.1002.
    PubMed     Text format    


  208. PLATZ E, Jhund PS, Claggett BL, Pfeffer MA, et al
    Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality.
    Eur J Heart Fail. 2017 Sep 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  209. BIERING-SORENSEN T, Querejeta Roca G, Hegde SM, Shah AM, et al
    Left ventricular ejection time is an independent predictor of incident heart failure in a community-based cohort.
    Eur J Heart Fail. 2017 Sep 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  210. WAGENAAR KP, Rutten FH, Klompstra L, Bhana Y, et al
    'heartfailurematters.org', an educational website for patients and carers from the Heart Failure Association of the European Society of Cardiology: objectives, use and future directions.
    Eur J Heart Fail. 2017 Sep 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  211. COTTER G, Metra M, Davison BA, Jondeau G, et al
    Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?
    Eur J Heart Fail. 2017 Sep 4. doi: 10.1002.
    PubMed     Text format     Abstract available


    August 2017
  212. D'ANGIOLELLA LS, Cortesi PA, Pitotti C, Ritrovato D, et al
    Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context.
    Eur J Heart Fail. 2017 Aug 28. doi: 10.1002.
    PubMed     Text format    


  213. GOHAR A, Chong JPC, Liew OW, den Ruijter H, et al
    The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Eur J Heart Fail. 2017 Aug 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  214. GAYAT E, Arrigo M, Littnerova S, Sato N, et al
    Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study.
    Eur J Heart Fail. 2017 Aug 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  215. COTTER G, Cohen-Solal A, Davison BA, Mebazaa A, et al
    RELAX-AHF, BLAST-AHF, TRUE-AHF, and other important truths in acute heart failure research.
    Eur J Heart Fail. 2017 Aug 24. doi: 10.1002.
    PubMed     Text format    


  216. ZAMORA E, Lupon J, Bayes-Genis A
    Obesity in heart failure: is it time to rethink the paradox? Reply.
    Eur J Heart Fail. 2017 Aug 24. doi: 10.1002.
    PubMed     Text format    


  217. BUTLER J, Hamo CE, Filippatos G, Pocock SJ, et al
    The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.
    Eur J Heart Fail. 2017 Aug 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  218. GREENBERG B
    Gene therapy for heart failure: time to go back to the drawing board.
    Eur J Heart Fail. 2017 Aug 24. doi: 10.1002.
    PubMed     Text format    


  219. MAGNUSSEN H, Canepa M, Zambito PE, Brusasco V, et al
    What can we learn from pulmonary function testing in heart failure?
    Eur J Heart Fail. 2017 Aug 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  220. PARISSIS J, Bistola V, Ikonomidis I, Triposkiadis F, et al
    Nitroxyl donors for acute heart failure: promising newcomers.
    Eur J Heart Fail. 2017 Aug 14. doi: 10.1002.
    PubMed     Text format    


  221. AMBROSY AP, Gheorghiade M
    Clinical profiles in acute heart failure: one size fits all or not at all?
    Eur J Heart Fail. 2017 Aug 8. doi: 10.1002.
    PubMed     Text format    


  222. AMBROSY AP, Gheorghiade M
    Real-world dosing of evidence-based medications for heart failure: embracing guideline recommendations and clinical judgement.
    Eur J Heart Fail. 2017 Aug 8. doi: 10.1002.
    PubMed     Text format    


  223. METRA M
    August 2017 at a glance: tailored treatment, acute heart failure and cardiac resynchronization.
    Eur J Heart Fail. 2017;19:969-970.
    PubMed     Text format    


    July 2017
  224. COGSWELL RJ, Norby FL, Gottesman RF, Chen LY, et al
    High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Jul 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  225. TITA C, Gilbert EM, Van Bakel AB, Grzybowski J, et al
    A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2017 Jul 5. doi: 10.1002.
    PubMed     Text format     Abstract available


    June 2017
  226. AMBROSY AP, Butler J, Gheorghiade M
    Clinical trials in acute heart failure: beginning of the end or end of the beginning?
    Eur J Heart Fail. 2017 Jun 28. doi: 10.1002.
    PubMed     Text format    


  227. BURNS KV, Gage RM, Curtin AE, Gorcsan J 3rd, et al
    Left ventricular-only pacing in heart failure patients with normal atrioventricular conduction improves global function and left ventricular regional mechanics compared with biventricular pacing: an adaptive cardiac resynchronization therapy sub-study
    Eur J Heart Fail. 2017 Jun 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  228. SHARMA A, Demissei BG, Tromp J, Hillege HL, et al
    A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure.
    Eur J Heart Fail. 2017 Jun 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  229. STEWART S
    Persistently misunderstood and malignant: the case of heart failure vs. cancer.
    Eur J Heart Fail. 2017 Jun 19. doi: 10.1002.
    PubMed     Text format    


  230. NIKOLOVSKA VUKADINOVIC A, Vukadinovic D, Borer J, Cowie M, et al
    Heart rate and its reduction in chronic heart failure and beyond.
    Eur J Heart Fail. 2017 Jun 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  231. RASTOGI A, Novak E, Platts AE, Mann DL, et al
    Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction.
    Eur J Heart Fail. 2017 Jun 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  232. ZAMAN S, Zaman SS, Scholtes T, Shun-Shin MJ, et al
    The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets.
    Eur J Heart Fail. 2017 Jun 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  233. BOHM M, Laufs U, Mahfoud F, Schirmer SH, et al
    Primum non nocere: the dangers of deferring heart failure therapy.
    Eur J Heart Fail. 2017 Jun 8. doi: 10.1002.
    PubMed     Text format    


  234. BOSCH L, Lam CSP, Gong L, Chan SP, et al
    Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Eur J Heart Fail. 2017 Jun 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  235. MUELLER C
    Clinical utility of biomarkers in heart failure.
    Eur J Heart Fail. 2017 Jun 5. doi: 10.1002.
    PubMed     Text format    


  236. LASSUS J
    Evaluating pulmonary congestion with lung ultrasound and the need to take the next steps in heart failure.
    Eur J Heart Fail. 2017 Jun 5. doi: 10.1002.
    PubMed     Text format    


  237. DEVORE AD, Hernandez AF
    Improving heart failure health: is there a secret Swedish sauce?
    Eur J Heart Fail. 2017 Jun 5. doi: 10.1002.
    PubMed     Text format    


  238. FERREIRA JP, Rossignol P, Machu JL, Sharma A, et al
    Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF.
    Eur J Heart Fail. 2017 Jun 5. doi: 10.1002.
    PubMed     Text format     Abstract available


  239. HERRERO-PUENTE P, Prieto-Garcia B, Garcia-Garcia M, Llorens P, et al
    The relationship of circulating relaxin-2 concentrations with short-term prognosis in patients with acute heart failure: the RELAHF study.
    Eur J Heart Fail. 2017 Jun 5. doi: 10.1002.
    PubMed     Text format     Abstract available


  240. FILIPPATOS G, Maggioni AP, Lam CSP, Pieske-Kraigher E, et al
    Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study.
    Eur J Heart Fail. 2017;19:782-791.
    PubMed     Text format     Abstract available


    May 2017
  241. TEERLINK JR, Metra M, Filippatos GS, Davison BA, et al
    Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study.
    Eur J Heart Fail. 2017 May 31. doi: 10.1002.
    PubMed     Text format     Abstract available


  242. DE CATERINA R
    Aspirin in heart failure: don't throw the baby (aspirin) out with the bathwater.
    Eur J Heart Fail. 2017 May 31. doi: 10.1002.
    PubMed     Text format    


  243. AHMED A, Blackman MR, White M, Anker SD, et al
    Emphasis on abdominal obesity as a modifier of eplerenone effect in heart failure: hypothesis-generating signals from EMPHASIS-HF.
    Eur J Heart Fail. 2017 May 30. doi: 10.1002.
    PubMed     Text format    


  244. ROY B, Woo MA, Wang DJJ, Fonarow GC, et al
    Reduced regional cerebral blood flow in patients with heart failure.
    Eur J Heart Fail. 2017 May 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  245. HARJOLA VP, Mullens W, Banaszewski M, Bauersachs J, et al
    Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
    Eur J Heart Fail. 2017 May 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  246. PLATZ E, Merz AA, Jhund PS, Vazir A, et al
    Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review.
    Eur J Heart Fail. 2017 May 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  247. VEGTER EL, van der Meer P, Voors AA
    Associations between volume status and circulating microRNAs in acute heart failure.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  248. CHIRINOS JA, Londono-Hoyos F, Zamani P, Beraun M, et al
    Effects of organic and inorganic nitrate on aortic and carotid haemodynamics in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  249. POPESCU BA, Beladan CC, Popescu AC
    Mechanical dyssynchrony in heart failure with preserved ejection fraction: a treatment target or a dead end?
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  250. METRA M, Ravera A, Filippatos G
    Understanding worsening heart failure as a therapeutic target: another step forward?
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  251. PASCUAL-FIGAL DA
    Acute heart failure and biomarkers: time also matters, don't relax.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  252. VADUGANATHAN M, Patel RB, Butler J, Metra M, et al
    Integrating electronic health records into the study of heart failure: promises and pitfalls.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


  253. VAN AELST LNL, Abraham M, Sadoune M, Lefebvre T, et al
    Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up.
    Eur J Heart Fail. 2017 May 17. doi: 10.1002.
    PubMed     Text format    


  254. EDELMANN F, Bobenko A, Gelbrich G, Hasenfuss G, et al
    Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial.
    Eur J Heart Fail. 2017 May 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  255. MORBACH C, Marx A, Kaspar M, Guder G, et al
    Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
    Eur J Heart Fail. 2017 May 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  256. PINTALHAO M, Castro-Chaves P, Bettencourt P
    Are circulating relaxin levels related to pulmonary hypertension in patients with heart failure? A reply.
    Eur J Heart Fail. 2017 May 4. doi: 10.1002.
    PubMed     Text format    


  257. MAMAS MA, Sperrin M, Watson MC, Coutts A, et al
    Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland.
    Eur J Heart Fail. 2017 May 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  258. GREENE SJ, Vaduganathan M, Gheorghiade M
    Finding the road to recovery: therapeutic and clinical trial implications of dysfunctional viable myocardium in heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2017 May 2. doi: 10.1002.
    PubMed     Text format    



  259. Abstracts of the Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, Paris, France, 29 April - 2 May 2017.
    Eur J Heart Fail. 2017;19 Suppl 1:5-601.
    PubMed     Text format    


  260. AHMAD T, Testani JM
    What happens to stable heart failure patients when they don't take their medicines?
    Eur J Heart Fail. 2017;19:650-651.
    PubMed     Text format    


  261. NAGELE MP
    Pulmonary artery pressure-based telemedicine in heart failure: ready for Europe?
    Eur J Heart Fail. 2017;19:670-672.
    PubMed     Text format    


  262. LEHLE K, Lubnow M, Philipp A, Foltan M, et al
    Prevalence of hemolysis and metabolic acidosis in patients with circulatory failure supported with extracorporeal life support: a marker for survival?
    Eur J Heart Fail. 2017;19 Suppl 2:110-116.
    PubMed     Text format     Abstract available


  263. ROELEVELD PP
    What is new in pediatric ECMO? 2016, a year in review.
    Eur J Heart Fail. 2017;19 Suppl 2:92-96.
    PubMed     Text format     Abstract available


  264. SOROKIN V, MacLaren G, Vidanapathirana PC, Delnoij T, et al
    Choosing the appropriate configuration and cannulation strategies for extracorporeal membrane oxygenation: the potential dynamic process of organ support and importance of hybrid modes.
    Eur J Heart Fail. 2017;19 Suppl 2:75-83.
    PubMed     Text format     Abstract available


  265. OSTADAL P, Rokyta R, Kruger A, Vondrakova D, et al
    Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): rationale and design of the multicenter randomized trial.
    Eur J Heart Fail. 2017;19 Suppl 2:124-127.
    PubMed     Text format     Abstract available


  266. DEN UIL CA, Jewbali LS, Heeren MJ, Constantinescu AA, et al
    Isolated left ventricular failure is a predictor of poor outcome in patients receiving veno-arterial extracorporeal membrane oxygenation.
    Eur J Heart Fail. 2017;19 Suppl 2:104-109.
    PubMed     Text format     Abstract available


    April 2017
  267. KOMAJDA M, Cowie MR, Tavazzi L, Ponikowski P, et al
    Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Eur J Heart Fail. 2017 Apr 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  268. CHIONCEL O, Mebazaa A, Harjola VP, Coats AJ, et al
    Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2017 Apr 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  269. KOMAJDA M, Isnard R, Cohen-Solal A, Metra M, et al
    Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Eur J Heart Fail. 2017 Apr 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  270. TEERLINK JR, Voors AA, Ponikowski P, Pang PS, et al
    Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Eur J Heart Fail. 2017 Apr 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  271. ANKER SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, et al
    Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
    Eur J Heart Fail. 2017 Apr 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  272. VINEREANU D, Margulescu AD
    The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction: add global longitudinal strain to the list.
    Eur J Heart Fail. 2017 Apr 19. doi: 10.1002.
    PubMed     Text format    


  273. FERREIRA JP, Mentz RJ, Pizard A, Pitt B, et al
    Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?
    Eur J Heart Fail. 2017 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  274. HULOT JS, Salem JE, Redheuil A, Collet JP, et al
    Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.
    Eur J Heart Fail. 2017 Apr 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  275. LUPON J, Diez-Lopez C, de Antonio M, Domingo M, et al
    Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Eur J Heart Fail. 2017 Apr 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  276. CHIONCEL O, Lainscak M, Seferovic PM, Anker SD, et al
    Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2017 Apr 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  277. TKACZYSZYN M, Comin-Colet J, Voors AA, van Veldhuisen DJ, et al
    Iron deficiency and red cell indices in patients with heart failure.
    Eur J Heart Fail. 2017 Apr 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  278. VENTURA HO, Messerli FH, Lavie CJ
    Observations on the blood pressure paradox in heart failure.
    Eur J Heart Fail. 2017 Apr 3. doi: 10.1002.
    PubMed     Text format    


  279. LYONS OD, Floras JS, Logan AG, Beanlands R, et al
    Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial.
    Eur J Heart Fail. 2017;19:579-587.
    PubMed     Text format     Abstract available


  280. DEFTEREOS S, Giannopoulos G, Panagopoulou V, Filippatos G, et al
    Surrogate endpoints in heart failure: (once again) use with caution.
    Eur J Heart Fail. 2017;19:563-565.
    PubMed     Text format    


  281. PLICHART M, Orvoen G, Jourdain P, Quinquis L, et al
    Brain natriuretic peptide usefulness in very elderly dyspnoeic patients: the BED study.
    Eur J Heart Fail. 2017;19:540-548.
    PubMed     Text format     Abstract available


  282. BRISTOW MR, Sharma K, Assmann SF, Linas S, et al
    Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCAT.
    Eur J Heart Fail. 2017;19:457-465.
    PubMed     Text format     Abstract available


  283. JANSWEIJER JA, Nieuwhof K, Russo F, Hoorntje ET, et al
    Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.
    Eur J Heart Fail. 2017;19:512-521.
    PubMed     Text format     Abstract available


  284. ZANNAD F
    Monitoring renal safety in mineralocorticoid receptor antagonist trials.
    Eur J Heart Fail. 2017;19:466-468.
    PubMed     Text format    


  285. BALLIGAND JL
    Cardiac beta3-adrenergic receptors in the clinical arena: the end of the beginning.
    Eur J Heart Fail. 2017;19:576-578.
    PubMed     Text format    


  286. SENNI M, Ferrero P, Iacovoni A
    Prognostic scores: one fits all?
    Eur J Heart Fail. 2017;19:588.
    PubMed     Text format    


  287. VAN LINTHOUT S, Tschope C
    Lost in markers? Time for phenomics and phenomapping in dilated cardiomyopathy.
    Eur J Heart Fail. 2017;19:499-501.
    PubMed     Text format    


    March 2017
  288. ROM O, Aviram M
    High-density lipoprotein-associated paraoxonase 1: a possible prognostic biomarker for heart failure?
    Eur J Heart Fail. 2017 Mar 31. doi: 10.1002.
    PubMed     Text format    


  289. TSUJI K, Sakata Y, Nochioka K, Miura M, et al
    Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
    Eur J Heart Fail. 2017 Mar 31. doi: 10.1002.
    PubMed     Text format     Abstract available


  290. LOFMAN I, Szummer K, Dahlstrom U, Jernberg T, et al
    Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Eur J Heart Fail. 2017 Mar 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  291. MONTERO D, Flammer AJ
    Exercise intolerance in heart failure with preserved ejection fraction: time to scrutinize diuretic therapy?
    Eur J Heart Fail. 2017 Mar 29. doi: 10.1002.
    PubMed     Text format    


  292. SCHMID FA, Schlager O, Keller P, Seifert B, et al
    Prognostic value of long-term blood pressure changes in patients with chronic heart failure.
    Eur J Heart Fail. 2017 Mar 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  293. COWIE MR, Filippatos GS, Alonso Garcia ML, Anker SD, et al
    New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.
    Eur J Heart Fail. 2017 Mar 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  294. DEVAUX Y, Creemers EE, Boon RA, Werfel S, et al
    Circular RNAs in heart failure.
    Eur J Heart Fail. 2017 Mar 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  295. PIEPOLI MF
    Obesity in heart failure: is it time to rethink the paradox?
    Eur J Heart Fail. 2017 Mar 24. doi: 10.1002.
    PubMed     Text format    


  296. D'ELIA E, Iacovoni A, Vaduganathan M, Lorini FL, et al
    Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.
    Eur J Heart Fail. 2017 Mar 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  297. BIERING-SORENSEN T, Shah SJ, Anand I, Sweitzer N, et al
    Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Mar 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  298. MCDONALD K, O'Hanlon R, Savage HO, Khushaba RN, et al
    Sleep-disordered breathing in chronic heart failure is highly variable when measured remotely using a novel non-contact biomotion sensor.
    Eur J Heart Fail. 2017 Mar 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  299. OLIVIER A, Pitt B, Girerd N, Lamiral Z, et al
    Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.
    Eur J Heart Fail. 2017 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  300. SHARMA K, Fang JC
    The heart-kidney relationship in heart failure: it's not you, it's me.
    Eur J Heart Fail. 2017 Mar 15. doi: 10.1002.
    PubMed     Text format    


  301. RICKENBACHER P, Kaufmann BA, Maeder MT, Bernheim A, et al
    Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Eur J Heart Fail. 2017 Mar 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  302. DOVANCESCU S, Pellicori P, Mabote T, Torabi A, et al
    The effects of short-term omission of daily medication on the pathophysiology of heart failure.
    Eur J Heart Fail. 2017 Mar 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  303. CLELAND JG, Teerlink JR, Davison BA, Shoaib A, et al
    Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studie
    Eur J Heart Fail. 2017 Mar 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  304. SLIWA K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, et al
    Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM.
    Eur J Heart Fail. 2017 Mar 8. doi: 10.1002.
    PubMed     Text format     Abstract available



  305. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
    Eur J Heart Fail. 2017;19:438.
    PubMed     Text format    


  306. DIERCKX R, Inglis SC, Clark RA, Prieto-Merino D, et al
    Telemedicine in heart failure: new insights from the Cochrane meta-analyses.
    Eur J Heart Fail. 2017;19:304-306.
    PubMed     Text format    


  307. PAN A
    The real-world evidence of heart failure co-morbidities.
    Eur J Heart Fail. 2017;19:434.
    PubMed     Text format    


  308. BRISTOW MR
    Genetic variation expressed in the brain may impact heart failure.
    Eur J Heart Fail. 2017;19:324-325.
    PubMed     Text format    


  309. MCDONALD K, Gallagher J
    The practice gap in heart failure-the elephant in the room.
    Eur J Heart Fail. 2017;19:301-303.
    PubMed     Text format    


  310. MAASS AH, DeJongste MJ, van der Meer P
    Neuromodulation for systolic heart failure: more than a placebo effect?
    Eur J Heart Fail. 2017;19:401-403.
    PubMed     Text format    



  311. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2017;19:437.
    PubMed     Text format    


  312. DEMISSEI BG, Postmus D, Cleland JG, O'Connor CM, et al
    Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.
    Eur J Heart Fail. 2017 Mar 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  313. VOORS AA, Ouwerkerk W, Zannad F, van Veldhuisen DJ, et al
    Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure.
    Eur J Heart Fail. 2017 Mar 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  314. PAPPALARDO F, Schulte C, Pieri M, Schrage B, et al
    Concomitant implantation of Impella(R) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock.
    Eur J Heart Fail. 2017;19:404-412.
    PubMed     Text format     Abstract available


  315. BORIANI G, Malavasi VL
    Patient outcome after implant of a cardioverter defibrillator in the 'real world': the key role of co-morbidities.
    Eur J Heart Fail. 2017;19:387-390.
    PubMed     Text format    


  316. BEHAR JM, Rajani R, Rinaldi CA
    Guided left ventricular lead placement for cardiac resynchronization therapy: an opportunity for image integration.
    Eur J Heart Fail. 2017;19:435.
    PubMed     Text format    


  317. LORUSSO R
    Are two crutches better than one? The ongoing dilemma on the effects and need for left ventricular unloading during veno-arterial extracorporeal membrane oxygenation.
    Eur J Heart Fail. 2017;19:413-415.
    PubMed     Text format    


    February 2017
  318. EMMENS JE, Ter Maaten JM, Voors AA
    Are circulating relaxin levels related to pulmonary hypertension in patients with heart failure?
    Eur J Heart Fail. 2017 Feb 28. doi: 10.1002.
    PubMed     Text format    


  319. PELLICORI P, Urbinati A, Shah P, MacNamara A, et al
    What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?
    Eur J Heart Fail. 2017 Feb 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  320. PAOLILLO S, Mapelli M, Bonomi A, Corra U, et al
    Prognostic role of beta-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.
    Eur J Heart Fail. 2017 Feb 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  321. VAN SPALL HG, Rahman T, Mytton O, Ramasundarahettige C, et al
    Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis.
    Eur J Heart Fail. 2017 Feb 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  322. LUND LH, Carrero JJ, Farahmand B, Henriksson KM, et al
    Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study.
    Eur J Heart Fail. 2017 Feb 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  323. PARASKEVAIDIS IA, Ikonomidis I, Simitsis P, Parissis J, et al
    Multidimensional contractile reserve predicts adverse outcome in patients with severe systolic heart failure: a 4-year follow-up study.
    Eur J Heart Fail. 2017 Feb 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  324. NAYOR M, Larson MG, Wang N, Santhanakrishnan R, et al
    The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.
    Eur J Heart Fail. 2017 Feb 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  325. GUSTAFSSON F, Rogers JG
    Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.
    Eur J Heart Fail. 2017 Feb 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  326. SCALI MC, Cortigiani L, Simionuc A, Gregori D, et al
    Exercise-induced B-lines identify worse functional and prognostic stage in heart failure patients with depressed left ventricular ejection fraction.
    Eur J Heart Fail. 2017 Feb 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  327. EMDIN M, Aimo A, Passino C, Vergaro G, et al
    Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly?
    Eur J Heart Fail. 2017 Feb 15. doi: 10.1002.
    PubMed     Text format    


  328. DEVORE AD, McNulty S, Alenezi F, Ersboll M, et al
    Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
    Eur J Heart Fail. 2017 Feb 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  329. HAMMADAH M, Kalogeropoulos AP, Georgiopoulou VV, Weber M, et al
    High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.
    Eur J Heart Fail. 2017 Feb 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  330. COWIE MR, Simon M, Klein L, Thokala P, et al
    The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.
    Eur J Heart Fail. 2017 Feb 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  331. LUND LH, Braunschweig F, Benson L, Stahlberg M, et al
    Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry.
    Eur J Heart Fail. 2017 Feb 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  332. HARJOLA P, Tolonen J, Boyd J, Mattila J, et al
    The role of pre-hospital management in acute heart failure.
    Eur J Heart Fail. 2017;19:287-289.
    PubMed     Text format    


  333. STEWART COATS AJ
    Early abnormalities of cerebral blood flow in mild non-ischaemic heart failure: part of a whole-body response?
    Eur J Heart Fail. 2017;19:269-270.
    PubMed     Text format    


  334. NAAR J, Jaye D, Linde C, Neuzil P, et al
    Spinal cord stimulation in heart failure: effect on disease-associated biomarkers.
    Eur J Heart Fail. 2017;19:283-286.
    PubMed     Text format    


  335. METRA M
    February 2017 at a glance: fibrosis, acute heart failure and neurologic abnormalities.
    Eur J Heart Fail. 2017;19:165-166.
    PubMed     Text format    


  336. AHMAD T, Testani JM
    Haemoconcentration as a treatment goal in heart failure: ready for prime time?
    Eur J Heart Fail. 2017;19:237-240.
    PubMed     Text format    


  337. GYONGYOSI M, Winkler J, Ramos I, Do QT, et al
    Myocardial fibrosis: biomedical research from bench to bedside.
    Eur J Heart Fail. 2017;19:177-191.
    PubMed     Text format     Abstract available


  338. PUYMIRAT E, Fagon JY, Aegerter P, Diehl JL, et al
    Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997-2012.
    Eur J Heart Fail. 2017;19:192-200.
    PubMed     Text format     Abstract available


    January 2017
  339. DEMISSEI BG, Cotter G, Prescott MF, Felker GM, et al
    A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  340. SOKOLSKI M, Zymlinski R, Biegus J, Siwolowski P, et al
    Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  341. PAPADAKI A, Martinez-Gonzalez MA, Alonso-Gomez A, Rekondo J, et al
    Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  342. GUAZZI M
    Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format    


  343. GRUSON D, Pouleur AC, Makris K, Chrysohoou C, et al
    Systematic vitamin D supplementation and monitoring: improving outcomes in heart failure?
    Eur J Heart Fail. 2017 Jan 24. doi: 10.1002.
    PubMed     Text format    


  344. DE KEULENAER GW, Segers VF, Zannad F, Brutsaert DL, et al
    The future of pleiotropic therapy in heart failure. Lessons from the benefits of exercise training on endothelial function.
    Eur J Heart Fail. 2017 Jan 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  345. TER MAATEN JM, Rao VS, Hanberg JS, Perry Wilson F, et al
    Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure.
    Eur J Heart Fail. 2017 Jan 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  346. GUAZZI M, van Heerebeek L, Paulus WJ
    Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention.
    Eur J Heart Fail. 2017 Jan 19. doi: 10.1002.
    PubMed     Text format    


  347. KOMAJDA M
    Liraglutide in heart failure: caution is needed.
    Eur J Heart Fail. 2017;19:78-79.
    PubMed     Text format    


  348. EZEKOWITZ JA, Armstrong PW
    Diabetes and heart failure in the crosshairs: where is the target?
    Eur J Heart Fail. 2017;19:66-68.
    PubMed     Text format    


  349. GWIZDALA A, Rozwadowska N, Kolanowski TJ, Malcher A, et al
    Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure.
    Eur J Heart Fail. 2017;19:148-157.
    PubMed     Text format     Abstract available


  350. BIERING-SORENSEN T, Santos M, Rivero J, McCullough SD, et al
    Left ventricular deformation at rest predicts exercise-induced elevation in pulmonary artery wedge pressure in patients with unexplained dyspnoea.
    Eur J Heart Fail. 2017;19:101-110.
    PubMed     Text format     Abstract available


  351. NAGELE MP, Steffel J, Robertson M, Singh JP, et al
    Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT.
    Eur J Heart Fail. 2017;19:80-87.
    PubMed     Text format     Abstract available


  352. TAMPAKAKIS E, Tedford RJ
    Balancing the positives and negatives of the diastolic pulmonary gradient.
    Eur J Heart Fail. 2017;19:98-100.
    PubMed     Text format    


  353. EL-BATTRAWY I, Borggrefe M, Akin I
    Predictors of mortality in Takotsubo cardiomyopathy.
    Eur J Heart Fail. 2017;19:158.
    PubMed     Text format    


    December 2016
  354. KOUDSTAAL S, Pujades-Rodriguez M, Denaxas S, Gho JM, et al
    Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people.
    Eur J Heart Fail. 2016 Dec 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  355. FARMAKIS D, Triposkiadis F, Lekakis J, Parissis J, et al
    Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management.
    Eur J Heart Fail. 2016 Dec 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  356. MATYAS C, Nemeth BT, Olah A, Torok M, et al
    Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
    Eur J Heart Fail. 2016 Dec 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  357. ANGERMANN CE, Kaspar M, Marx A, Kittel-Schneider S, et al
    A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study.
    Eur J Heart Fail. 2016 Dec 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  358. BUNDGAARD H, Axelsson A, Hartvig Thomsen J, Sorgaard M, et al
    The-first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial.
    Eur J Heart Fail. 2016 Dec 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  359. SABBAH HN
    Silent disease progression in clinically stable heart failure.
    Eur J Heart Fail. 2016 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  360. SILVESTRE OM, Goncalves A, Nadruz W Jr, Claggett B, et al
    Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study.
    Eur J Heart Fail. 2016 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  361. CLELAND JG
    Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably!
    Eur J Heart Fail. 2016 Dec 11. doi: 10.1002.
    PubMed     Text format    


  362. BOHM M
    Heart rate: from heart failure to chronic diseases and cancer. Is there a role for supportive care by heart rate reduction?
    Eur J Heart Fail. 2016 Dec 4. doi: 10.1002.
    PubMed     Text format    


  363. VON HAEHLING S, Papp Z, Anker SD
    ESC Heart Failure: a new journal aims to broaden heart failure views.
    Eur J Heart Fail. 2016;18:1415-1419.
    PubMed     Text format    


    November 2016
  364. DUCA F, Zotter-Tufaro C, Kammerlander AA, Panzenbock A, et al
    Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure.
    Eur J Heart Fail. 2016 Nov 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  365. REDDY YN, Borlaug BA
    Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 Nov 21. doi: 10.1002.
    PubMed     Text format    


  366. LIU LC, Hummel YM, van der Meer P, Berger RM, et al
    Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension.
    Eur J Heart Fail. 2016 Nov 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  367. ROSSIGNOL P, Girerd N, Bakris G, Vardeny O, et al
    Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.
    Eur J Heart Fail. 2016 Nov 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  368. CANNON JA, Shen L, Jhund PS, Kristensen SL, et al
    Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2016 Nov 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  369. GORTER TM, Rienstra M, van Veldhuisen DJ
    Right ventricular dysfunction in heart failure with reduced vs. preserved ejection fraction: non-identical twins?
    Eur J Heart Fail. 2016 Nov 17. doi: 10.1002.
    PubMed     Text format    


  370. GHIO S, Guazzi M, Scardovi AB, Klersy C, et al
    Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.
    Eur J Heart Fail. 2016 Nov 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  371. ERKELENS CD, van der Wal HH, de Jong BM, Elting JW, et al
    Dynamics of cerebral blood flow in patients with mild non-ischaemic heart failure.
    Eur J Heart Fail. 2016 Nov 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  372. PACKER M, Holcomb R, Abraham WT, Anker S, et al
    Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure.
    Eur J Heart Fail. 2016 Nov 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  373. HEGGERMONT WA, Papageorgiou AP, Heymans S, van Bilsen M, et al
    Metabolic support for the heart: complementary therapy for heart failure?
    Eur J Heart Fail. 2016 Nov 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  374. PARISSIS J, Nikolaou M, Mebazaa A
    The Model for End-stage Liver Disease score in acute heart failure: hepatorenal dysfunction hides behind.
    Eur J Heart Fail. 2016 Nov 4. doi: 10.1002.
    PubMed     Text format    


  375. KAJIMOTO K, Takano T
    Role of functional mitral regurgitation in heart failure with preserved ejection fraction: an unrecognized protagonist?: reply.
    Eur J Heart Fail. 2016 Nov 4. doi: 10.1002.
    PubMed     Text format    


  376. TRIPOSKIADIS F, Pieske B, Butler J, Parissis J, et al
    Global left atrial failure in heart failure.
    Eur J Heart Fail. 2016;18:1307-1320.
    PubMed     Text format     Abstract available


  377. JHUND PS
    Geographic variation in heart failure-a matter of celebration or condemnation?
    Eur J Heart Fail. 2016;18:1329-1330.
    PubMed     Text format    


  378. METRA M
    November 2016 at a glance: the left atrium, screening for heart failure, multimodality imaging for cardiac resynchronization therapy.
    Eur J Heart Fail. 2016;18:1305-1306.
    PubMed     Text format    


  379. MEIJERS WC, de Boer RA, Ho JE
    Biomarkers to identify and prevent new-onset heart failure in the community.
    Eur J Heart Fail. 2016;18:1351-1352.
    PubMed     Text format    


  380. YANG H, Negishi K, Wang Y, Nolan M, et al
    Echocardiographic screening for non-ischaemic stage B heart failure in the community.
    Eur J Heart Fail. 2016;18:1331-1339.
    PubMed     Text format     Abstract available


  381. HAUGAA KH, Edvardsen T
    Global longitudinal strain: the best biomarker for predicting prognosis in heart failure?
    Eur J Heart Fail. 2016;18:1340-1341.
    PubMed     Text format    


    October 2016
  382. ARRIGO M, Gayat E, Parenica J, Ishihara S, et al
    Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry.
    Eur J Heart Fail. 2016 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  383. TARGHER G, Dauriz M, Laroche C, Temporelli PL, et al
    In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2016 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  384. JORSAL A, Kistorp C, Holmager P, Tougaard RS, et al
    Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
    Eur J Heart Fail. 2016 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  385. COIRO S, Girerd N, Rossignol P, Ferreira JP, et al
    Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myoc
    Eur J Heart Fail. 2016 Oct 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  386. DIEZ J
    Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy.
    Eur J Heart Fail. 2016 Oct 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  387. MEIJERS WC, van der Velde AR, Muller Kobold AC, Dijck-Brouwer J, et al
    Variability of biomarkers in patients with chronic heart failure and healthy controls.
    Eur J Heart Fail. 2016 Oct 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  388. KLIP IT, Voors AA, Swinkels DW, Bakker SJ, et al
    Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community.
    Eur J Heart Fail. 2016 Oct 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  389. BREIDTHARDT T, Weidmann ZM, Twerenbold R, Gantenbein C, et al
    Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function.
    Eur J Heart Fail. 2016 Oct 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  390. GREENE SJ, Fonarow GC, Solomon SD, Subacius HP, et al
    Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.
    Eur J Heart Fail. 2016 Oct 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  391. NAGY AI, Venkateshvaran A, Merkely B, Lund LH, et al
    Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease.
    Eur J Heart Fail. 2016 Oct 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  392. OBOKATA M, Borlaug BA
    Right ventricular dysfunction and pulmonary hypertension in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 Oct 13. doi: 10.1002.
    PubMed     Text format    


  393. BIEGUS J, Zymlinski R, Sokolski M, Siwolowski P, et al
    Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.
    Eur J Heart Fail. 2016 Oct 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  394. METRA M
    October 2016 at a glance: treatment of heart failure.
    Eur J Heart Fail. 2016;18:1209-1210.
    PubMed     Text format    


  395. VADUGANATHAN M, Patel RB, Yancy CW
    Stroke prevention in heart failure and sinus rhythm: where do we go from here?
    Eur J Heart Fail. 2016;18:1267-1269.
    PubMed     Text format    


  396. CHAGGAR PS, Williams SG, Yonan N, Fildes J, et al
    Myocardial recovery with mechanical circulatory support.
    Eur J Heart Fail. 2016;18:1220-1227.
    PubMed     Text format     Abstract available


  397. REGOLI F, Bongiorni MG, Rordorf R, Santamaria M, et al
    High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.
    Eur J Heart Fail. 2016;18:1270-1277.
    PubMed     Text format     Abstract available


    September 2016
  398. FITCHETT DH, Udell JA, Inzucchi SE
    Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.
    Eur J Heart Fail. 2016 Sep 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  399. GORTER TM, Hoendermis ES, van Veldhuisen DJ, Voors AA, et al
    Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  400. NIEWINSKI P, Janczak D, Rucinski A, Tubek S, et al
    Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  401. DINI FL, Carluccio E, Simioniuc A, Biagioli P, et al
    Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  402. ADAMO L, Nassif ME, Novak E, LaRue SJ, et al
    Prevalence of lactic acidaemia in patients with advanced heart failure and depressed cardiac output.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  403. MARTINSON M, Bharmi R, Dalal N, Abraham WT, et al
    Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial.
    Eur J Heart Fail. 2016 Sep 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  404. MELENOVSKY V, Petrak J, Mracek T, Benes J, et al
    Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis.
    Eur J Heart Fail. 2016 Sep 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  405. SANTAS E, Nunez E, Nunez J
    Role of functional mitral regurgitation in heart failure with preserved ejection fraction: an unrecognized protagonist?
    Eur J Heart Fail. 2016 Sep 19. doi: 10.1002.
    PubMed     Text format    


  406. ADAMSON PB, Ginn G, Anker SD, Bourge RC, et al
    Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials.
    Eur J Heart Fail. 2016 Sep 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  407. KITAI T, Grodin JL, Mentz RJ, Hernandez AF, et al
    Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
    Eur J Heart Fail. 2016 Sep 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  408. IBRAHIM I, Kuan WS, Frampton C, Troughton R, et al
    Superior performance of N-terminal pro brain natriuretic peptide for diagnosis of acute decompensated heart failure in an Asian compared with a Western setting.
    Eur J Heart Fail. 2016 Sep 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  409. ADELBORG K, Horvath-Puho E, Ording A, Pedersen L, et al
    Heart failure and risk of dementia: a Danish nationwide population-based cohort study.
    Eur J Heart Fail. 2016 Sep 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  410. OMERSA D, Farkas J, Erzen I, Lainscak M, et al
    National trends in heart failure hospitalization rates in Slovenia 2004-2012.
    Eur J Heart Fail. 2016 Sep 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  411. SHAHID F, Shantsila E, Lip GY
    Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?
    Eur J Heart Fail. 2016;18:1172-4.
    PubMed     Text format    


  412. HAWKINS NM, Jhund PS, Pozzi A, O'Meara E, et al
    Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment.
    Eur J Heart Fail. 2016;18:1162-71.
    PubMed     Text format     Abstract available


  413. KONSTANTINIDES SV
    Trends in pregnancy outcomes in patients with pulmonary hypertension: still a long way to go.
    Eur J Heart Fail. 2016;18:1129-31.
    PubMed     Text format    


    August 2016
  414. BORIANI G, Da Costa A, Quesada A, Ricci RP, et al
    Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial.
    Eur J Heart Fail. 2016 Aug 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  415. JESSUP M
    The BA-HEF trial in Africa: a welcome addition to heart failure history.
    Eur J Heart Fail. 2016 Aug 10. doi: 10.1002.
    PubMed     Text format    


  416. PACKER M
    Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA.
    Eur J Heart Fail. 2016 Aug 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  417. KAPELIOS CJ, Malliaras K, Nanas JN
    Dosing of loop diuretics in chronic heart failure: it's time for evidence.
    Eur J Heart Fail. 2016 Aug 5. doi: 10.1002.
    PubMed     Text format    


  418. PINTALHAO M, Castro-Chaves P, Vasques-Novoa F, Goncalves F, et al
    Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload.
    Eur J Heart Fail. 2016 Aug 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  419. THUM T
    Novel models and mechanisms of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016;18:998-9.
    PubMed     Text format    


  420. METRA M
    August 2016 at a glance: the new ESC guidelines, and pathophysiology, epidemiology and prognosis of heart failure.
    Eur J Heart Fail. 2016;18:889-90.
    PubMed     Text format    


    July 2016
  421. YE S, Qian M, Zhao B, Buchsbaum R, et al
    CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.
    Eur J Heart Fail. 2016 Jul 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  422. BAEZA-TRINIDAD R, Mosquera-Lozano JD, El Bikri L
    Assessment of bendopnoea impact on decompensated heart failure.
    Eur J Heart Fail. 2016 Jul 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  423. DAMMAN K, Solomon SD, Pfeffer MA, Swedberg K, et al
    Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme.
    Eur J Heart Fail. 2016 Jul 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  424. LINDE C, Eriksson MJ, Hage C, Wallen H, et al
    Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants.
    Eur J Heart Fail. 2016 Jul 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  425. SLIWA K, van Hagen IM, Budts W, Swan L, et al
    Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology.
    Eur J Heart Fail. 2016 Jul 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  426. DELGADO JF, Bueno H
    Heart failure: health is priceless... but still expensive.
    Eur J Heart Fail. 2016 Jul 4. doi: 10.1002.
    PubMed     Text format    


  427. LUO N, Mentz RJ
    A Gordian knot: disentangling comorbidities in heart failure.
    Eur J Heart Fail. 2016 Jul 4. doi: 10.1002.
    PubMed     Text format    


  428. NUNEZ J, Garcia-Blas S, Comin-Colet J
    Iron deficiency and risk of early readmission following hospitalization for acute heart failure. Reply.
    Eur J Heart Fail. 2016;18:881.
    PubMed     Text format    


  429. MCDONAGH TA
    Ironing out iron deficiency in heart failure.
    Eur J Heart Fail. 2016;18:796-7.
    PubMed     Text format    


    June 2016
  430. SOLOMON SD, Claggett B, McMurray JJ, Hernandez AF, et al
    Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.
    Eur J Heart Fail. 2016 Jun 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  431. TRIPOSKIADIS F, Giamouzis G, Parissis J, Starling RC, et al
    Reframing the association and significance of co-morbidities in heart failure.
    Eur J Heart Fail. 2016 Jun 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  432. MAGNANI G, Giugliano RP, Ruff CT, Murphy SA, et al
    Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.
    Eur J Heart Fail. 2016 Jun 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  433. VADUGANATHAN M, Patel RB, Greene SJ, Gheorghiade M, et al
    Targeting the vulnerable phase of heart failure: initiate novel therapies in stable patients prior to hospitalization.
    Eur J Heart Fail. 2016 Jun 23. doi: 10.1002.
    PubMed     Text format    


  434. BAUERSACHS J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, et al
    Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
    Eur J Heart Fail. 2016 Jun 23. doi: 10.1002.
    PubMed     Text format    


  435. BRAUNSCHWEIG F, Linde C, Benson L, Stahlberg M, et al
    New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
    Eur J Heart Fail. 2016 Jun 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  436. ZAMORA E, Lupon J, Enjuanes C, Pascual-Figal D, et al
    No benefit from the obesity paradox for diabetic patients with heart failure.
    Eur J Heart Fail. 2016 Jun 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  437. EMAMI A, von Haehling S
    Iron deficiency and risk of early readmission following hospitalization for acute heart failure.
    Eur J Heart Fail. 2016 Jun 13. doi: 10.1002.
    PubMed     Text format    


  438. RUTTEN FH, Guder G
    The role of beta-blockers in outcomes of patients hospitalized for heart failure and chronic obstructive pulmonary disease.
    Eur J Heart Fail. 2016 Jun 12. doi: 10.1002.
    PubMed     Text format    


  439. VARDENY O, Claggett B, Packer M, Zile MR, et al
    Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.
    Eur J Heart Fail. 2016 Jun 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  440. CHRIST M, Stork S, Dorr M, Heppner HJ, et al
    Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System.
    Eur J Heart Fail. 2016 Jun 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  441. ANKER SD, Schroeder S, Atar D, Bax JJ, et al
    Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].
    Eur J Heart Fail. 2016;18:727.
    PubMed     Text format    


  442. PARISSIS J, Farmakis D, Triposkiadis F
    Heart failure registries: how far can we go?
    Eur J Heart Fail. 2016;18:626-8.
    PubMed     Text format    


  443. CRESPO-LEIRO MG, Anker SD, Maggioni AP, Coats AJ, et al
    European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
    Eur J Heart Fail. 2016;18:613-25.
    PubMed     Text format     Abstract available


  444. METRA M
    June 2016 at a glance: epidemiology, renal impairment, heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016;18:587.
    PubMed     Text format    


    May 2016
  445. ALTA S, Onat A, Kaya A
    Shared underlying dynamics between heart failure and cancer: autoimmune activation?
    Eur J Heart Fail. 2016 May 30. doi: 10.1002.
    PubMed     Text format    


  446. VIDAN MT, Bueno H
    Trends in heart failure: going in the right direction?
    Eur J Heart Fail. 2016 May 25. doi: 10.1002.
    PubMed     Text format    


  447. RILEY JP, Astin F, Crespo-Leiro MG, Deaton CM, et al
    Heart Failure Association of the European Society of Cardiology heart failure nurse curriculum.
    Eur J Heart Fail. 2016 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  448. FARMAKIS D, Koeck T, Mullen W, Parissis J, et al
    Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates.
    Eur J Heart Fail. 2016 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  449. KAJIMOTO K, Sato N, Takano T
    Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction.
    Eur J Heart Fail. 2016 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  450. KOMAJDA M, Tavazzi L, Swedberg K, Bohm M, et al
    Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT.
    Eur J Heart Fail. 2016 May 22. doi: 10.1002.
    PubMed     Text format     Abstract available



  451. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribut
    Eur J Heart Fail. 2016 May 20. doi: 10.1002.
    PubMed     Text format    


  452. ANTMAN EM, Bax J, Chazal RA, Creager MA, et al
    Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.
    Eur J Heart Fail. 2016 May 20. doi: 10.1002.
    PubMed     Text format    


  453. SLIWA K, Damasceno A, Davison BA, Mayosi BM, et al
    Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF).
    Eur J Heart Fail. 2016 May 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  454. TOKITSU T, Yamamoto E, Hirata Y, Kusaka H, et al
    Clinical significance of pulse pressure in patients with heart failure with preserved left ventricular ejection fraction.
    Eur J Heart Fail. 2016 May 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  455. CANNON JA, Shen L, Jhund PS, Anand IS, et al
    Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
    Eur J Heart Fail. 2016 May 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  456. ZAFRIR B, Salman N, Crespo-Leiro MG, Anker SD, et al
    Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2016 May 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  457. SENNI M, McMurray JJ, Wachter R, McIntyre HF, et al
    Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.
    Eur J Heart Fail. 2016 May 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  458. BIEGUS J, Hillege HL, Postmus D, Valente MA, et al
    Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
    Eur J Heart Fail. 2016 May 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  459. GOUDA P, Brown P, Rowe BH, McAlister FA, et al
    Insights into the importance of the electrocardiogram in patients with acute heart failure.
    Eur J Heart Fail. 2016 May 5. doi: 10.1002.
    PubMed     Text format     Abstract available


  460. PRIMESSNIG U, Schonleitner P, Holl A, Pfeiffer S, et al
    Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 May 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  461. BAYES-GENIS A, Barallat J, Lupon J
    Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction?
    Eur J Heart Fail. 2016;18:576.
    PubMed     Text format    


  462. VAN AELST LN, Celutkiene J, Mebazaa A
    Advanced heart failure: look right to prognosticate right!
    Eur J Heart Fail. 2016;18:573-5.
    PubMed     Text format    


  463. CLARK AL
    Tipping the scales toward fitness as a key modifier of the obesity paradox in heart failure.
    Eur J Heart Fail. 2016;18:554-5.
    PubMed     Text format    


  464. PIEPOLI MF, Corra U, Veglia F, Bonomi A, et al
    Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group.
    Eur J Heart Fail. 2016;18:545-53.
    PubMed     Text format     Abstract available


  465. MAGGIONI AP, Piepoli MF
    The European Society of Cardiology Heart Failure Association Annual Congress.
    Eur J Heart Fail. 2016;18:454-5.
    PubMed     Text format    


  466. OZKAN J
    Frank Ruschitzka MD FESC FRCP shares some thoughts on the future direction of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2016;18:453-4.
    PubMed     Text format    


  467. OZKAN J
    Gerasimos Filippatos MD FESC FHFA, outgoing president of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2016;18:452-3.
    PubMed     Text format    



  468. Abstracts of the Heart Failure 2016 Conference, Florence, Italy, 21-24 May 2016.
    Eur J Heart Fail. 2016;18 Suppl 1:8-521.
    PubMed     Text format    


    April 2016
  469. NAGAI T, Nishimura K, Honma T, Higashiyama A, et al
    Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure.
    Eur J Heart Fail. 2016 Apr 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  470. VOORS AA, Anker SD, Cleland JG, Dickstein K, et al
    A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
    Eur J Heart Fail. 2016 Apr 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  471. MAHFOUD F, Ewen S, Bohm M
    Renal denervation in patients with heart failure with preserved ejection fraction: end of the beginning?
    Eur J Heart Fail. 2016 Apr 27. doi: 10.1002.
    PubMed     Text format    


  472. VADUGANATHAN M, Pallais JC, Fenves AZ, Butler J, et al
    Serum chloride in heart failure: a salty prognosis.
    Eur J Heart Fail. 2016 Apr 27. doi: 10.1002.
    PubMed     Text format    


  473. MAGGIONI AP
    Outcome improvement of patients with heart failure and reduced ejection fraction: has it ended in the new millennium?
    Eur J Heart Fail. 2016 Apr 27. doi: 10.1002.
    PubMed     Text format    


  474. JACKSON CE, Haig C, Welsh P, Dalzell JR, et al
    The incremental prognostic and clinical value of multiple novel biomarkers in heart failure.
    Eur J Heart Fail. 2016 Apr 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  475. DAVISON BA, Metra M, Senger S, Edwards C, et al
    Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Eur J Heart Fail. 2016 Apr 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  476. FARRE N, Vela E, Cleries M, Bustins M, et al
    Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients.
    Eur J Heart Fail. 2016 Apr 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  477. STASZEWSKY L, Cortesi L, Tettamanti M, Dal Bo GA, et al
    Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
    Eur J Heart Fail. 2016 Apr 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  478. VAN VELDHUISEN DJ, de Boer RA
    Ischaemia in heart failure with preserved ejection fraction; is it important?
    Eur J Heart Fail. 2016 Apr 20. doi: 10.1002.
    PubMed     Text format    


  479. KOMAJDA M, Anker SD, Cowie MR, Filippatos GS, et al
    Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
    Eur J Heart Fail. 2016 Apr 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  480. JHUND PS, Tavazzi L
    Has the 'epidemic' of heart failure been replaced by a tsunami of co-morbidities?
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format    


  481. MONNERET D, Roche F, Bonnefont-Rousselot D
    Plasma endothelin-1 in acute heart failure: pathophysiological and preanalytical considerations.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format    


  482. VIDAN MT, Blaya-Novakova V, Sanchez E, Ortiz J, et al
    Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  483. ANKER SD, Schroeder S, Atar D, Bax JJ, et al
    Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  484. ALFALEH H, Elasfar AA, Ullah A, AlHabib KF, et al
    Worsening heart failure in 'real-world' clinical practice: predictors and prognostic impact.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  485. WESTENBRINK BD, Brugts JJ, McDonagh TA, Filippatos G, et al
    Heart failure specialization in Europe.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format    


  486. BORIANI G, Berti E, Belotti LM, Biffi M, et al
    Cardiac device therapy in patients with left ventricular dysfunction and heart failure: 'real-world' data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital).
    Eur J Heart Fail. 2016 Apr 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  487. VOLPE M, Battistoni A, Mastromarino V
    Natriuretic peptides and volume handling in heart failure: the paradigm of a new treatment.
    Eur J Heart Fail. 2016;18:442-4.
    PubMed     Text format    


    March 2016
  488. NUNEZ J, Comin-Colet J, Minana G, Nunez E, et al
    Iron deficiency and risk of early readmission following a hospitalization for acute heart failure.
    Eur J Heart Fail. 2016 Mar 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  489. BUTLER J, Gheorghiade M, Metra M
    Moving away from symptoms-based heart failure treatment: misperceptions and real risks for patients with heart failure.
    Eur J Heart Fail. 2016 Mar 17. doi: 10.1002.
    PubMed     Text format    


  490. SHOAIB A, Farag M, Nasir M, John J, et al
    Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  491. FREA S, Pidello S, Bovolo V, Iacovino C, et al
    Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  492. PATEL HC, Rosen SD, Hayward C, Vassiliou V, et al
    Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trial.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  493. BOHM M, Lloyd SM, Ford I, Borer JS, et al
    Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT.
    Eur J Heart Fail. 2016 Mar 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  494. HARJOLA VP, Mebazaa A, Celutkiene J, Bettex D, et al
    Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.
    Eur J Heart Fail. 2016;18:226-41.
    PubMed     Text format     Abstract available


  495. METRA M
    March 2016 at a glance. Focus on right ventricular failure and acute heart failure.
    Eur J Heart Fail. 2016;18:225.
    PubMed     Text format    


    February 2016
  496. THORVALDSEN T, Benson L, Dahlstrom U, Edner M, et al
    Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  497. VEGTER EL, van der Meer P, de Windt LJ, Pinto YM, et al
    MicroRNAs in heart failure: from biomarker to target for therapy.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  498. PEARSE SG, Cowie MR
    Sleep-disordered breathing in heart failure.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  499. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  500. TER MAATEN JM, Damman K, Verhaar MC, Paulus WJ, et al
    Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
    Eur J Heart Fail. 2016 Feb 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  501. CHIN KL, Collier TJ, Pitt B, McMurray JJ, et al
    Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study.
    Eur J Heart Fail. 2016 Feb 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  502. VON HAEHLING S
    Adding insult to injury: heart failure and incident cancer.
    Eur J Heart Fail. 2016 Feb 1. doi: 10.1002.
    PubMed     Text format    



  503. Corrigendum to 'What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative'[Eur J Heart Fail 2016; 18:66-70].
    Eur J Heart Fail. 2016;18:217.
    PubMed     Text format    


  504. GILBERT RE, Ruschitzka F
    Henry Krum, Pioneering Heart Failure Researcher.
    Eur J Heart Fail. 2016;18:125-6.
    PubMed     Text format    


  505. SINAGRA G, Fabris E
    Direct cellular reprogramming: the hopes and the hurdles.
    Eur J Heart Fail. 2016;18:157-9.
    PubMed     Text format    


  506. VERBRUGGE FH
    Decongestion: more than meets the eye!
    Eur J Heart Fail. 2016;18:192-4.
    PubMed     Text format    


  507. METRA M
    February 2016 at a glance. Focus issue on cardiac regeneration, medical treatment and cardiac devices.
    Eur J Heart Fail. 2016;18:127.
    PubMed     Text format    


  508. VADUGANATHAN M, Prasad V
    Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication?
    Eur J Heart Fail. 2016;18:128-32.
    PubMed     Text format    


  509. STOLFO D, Tonet E, Merlo M, Barbati G, et al
    Early right ventricular response to cardiac resynchronization therapy: impact on clinical outcomes.
    Eur J Heart Fail. 2016;18:205-13.
    PubMed     Text format     Abstract available


  510. BATTY JA, Lima JA Jr, Kunadian V
    Direct cellular reprogramming for cardiac repair and regeneration.
    Eur J Heart Fail. 2016;18:145-56.
    PubMed     Text format     Abstract available


  511. SCHUSSLER-LENZ M, Beuneu C, Menezes-Ferreira M, Jekerle V, et al
    Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints.
    Eur J Heart Fail. 2016;18:133-41.
    PubMed     Text format     Abstract available


  512. VADUGANATHAN M, Goldsmith SR, Senni M, Butler J, et al
    Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial.
    Eur J Heart Fail. 2016;18:185-91.
    PubMed     Text format     Abstract available


    January 2016
  513. PARISSIS J, Farmakis D, Kadoglou N, Ikonomidis I, et al
    Body mass index in acute heart failure: association with clinical profile, therapeutic management and in-hospital outcome.
    Eur J Heart Fail. 2016 Jan 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  514. STARLING RC
    Augmenting outcomes in advanced heart failure: a lot to learn.
    Eur J Heart Fail. 2016 Jan 28. doi: 10.1002.
    PubMed     Text format    


  515. JANKOWSKA EA, Tkaczyszyn M, Suchocki T, Drozd M, et al
    Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
    Eur J Heart Fail. 2016 Jan 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  516. WONG YW, Mentz RJ, Felker GM, Ezekowitz J, et al
    Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials.
    Eur J Heart Fail. 2016 Jan 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  517. KLERSY C, Boriani G, De Silvestri A, Mairesse GH, et al
    Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized, controlled trials in patients with heart failure.
    Eur J Heart Fail. 2016 Jan 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  518. MCKIE PM, Schirger JA, Benike SL, Harstad LK, et al
    Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure.
    Eur J Heart Fail. 2016 Jan 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  519. DIAS A, Franco E
    A position statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology: What about racial differences?
    Eur J Heart Fail. 2016 Jan 21. doi: 10.1002.
    PubMed     Text format    


  520. TERZIC A, Behfar A, Filippatos G
    Clinical development plan for regenerative therapy in heart failure.
    Eur J Heart Fail. 2016 Jan 21. doi: 10.1002.
    PubMed     Text format    


  521. GROTE BEVERBORG N, van der Wal HH, Klip IT, Voors AA, et al
    High serum erythropoietin levels are related to heart failure development in subjects from the general population with albuminuria: data from PREVEND.
    Eur J Heart Fail. 2016 Jan 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  522. TEKTONIDIS TG, Akesson A, Gigante B, Wolk A, et al
    Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men.
    Eur J Heart Fail. 2016 Jan 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  523. TESTANI JM, Hanberg JS, Arroyo JP, Brisco MA, et al
    Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure.
    Eur J Heart Fail. 2016 Jan 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  524. MAGGIONI AP, Orso F, Calabria S, Rossi E, et al
    The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database.
    Eur J Heart Fail. 2016 Jan 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  525. BANKE A, Schou M, Videbaek L, Moller JE, et al
    Incidence of cancer in patients with chronic heart failure: a long-term follow-up study.
    Eur J Heart Fail. 2016 Jan 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  526. SUEMATSU Y, Miura SI, Goto M, Matsuo Y, et al
    LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice.
    Eur J Heart Fail. 2016 Jan 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  527. RUIZ-ESPARZA GU, Segura-Ibarra V, Cordero-Reyes AM, Youker KA, et al
    A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics.
    Eur J Heart Fail. 2016 Jan 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  528. VAN RIET EE, Hoes AW, Wagenaar KP, Limburg A, et al
    Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  529. COIRO S, Chouihed T, Girerd N
    Lung ultrasound - The extension of clinical examination in patients with acute heart failure: Reply.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format    


  530. KAMPERIDIS V, Delgado V, van Mieghem NM, Kappetein AP, et al
    Diagnosis and management of aortic valve stenosis in patients with heart failure.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  531. GOLIASCH G, Pavo N, Zotter-Tufaro C, Kammerlander A, et al
    Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  532. RIZZI MA, Alquezar A, Marcuello JM, Ontiveros HH, et al
    The Redin SCORE: useful, but not for all.
    Eur J Heart Fail. 2016;18:116.
    PubMed     Text format    


  533. ALVAREZ-GARCIA J, Ferrero-Gregori A, Puig T, Cinca J, et al
    The Redin SCORE: useful, but not for all: reply.
    Eur J Heart Fail. 2016;18:117.
    PubMed     Text format    


  534. BRAMLAGE P, Swift SL, Thoenes M, Minguet J, et al
    Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease.
    Eur J Heart Fail. 2016;18:28-37.
    PubMed     Text format     Abstract available


    December 2015
  535. TER MAATEN JM, Voors AA
    Renal dysfunction in heart failure with a preserved ejection fraction: cause or consequence?
    Eur J Heart Fail. 2015 Dec 28. doi: 10.1002.
    PubMed     Text format    


  536. SAMSKY MD, Dunning A, DeVore AD, Schulte PJ, et al
    Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
    Eur J Heart Fail. 2015 Dec 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  537. DAMMAN K, Kjekshus J, Wikstrand J, Cleland JG, et al
    Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Eur J Heart Fail. 2015 Dec 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  538. BHANDARI SS, Narayan H, Jones DJ, Suzuki T, et al
    Plasma growth hormone is a strong predictor of risk at 1 year in acute heart failure.
    Eur J Heart Fail. 2015 Dec 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  539. HAWKINS NM, Virani SA, Sperrin M, Buchan IE, et al
    Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges.
    Eur J Heart Fail. 2015 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  540. PEREZ AL, Grodin JL, Wu Y, Hernandez AF, et al
    Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy.
    Eur J Heart Fail. 2015 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  541. BARTUNEK J, Davison B, Sherman W, Povsic T, et al
    Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.
    Eur J Heart Fail. 2015 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  542. ELDER DH, Singh JS, Levin D, Donnelly LA, et al
    Mean HbA and mortality in diabetic individuals with heart failure: a population cohort study.
    Eur J Heart Fail. 2015 Dec 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  543. UNGER ED, Dubin RF, Deo R, Daruwalla V, et al
    Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  544. DEMISSEI BG, Cleland JG, O'Connor CM, Metra M, et al
    Optimizing clinical use of biomarkers in high-risk acute heart failure patients.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  545. VADUGANATHAN M, Michel A, Hall K, Mulligan C, et al
    Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  546. PITT B, Weir MR
    Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format    


  547. SPERANDEO M, Di Stolfo G, Carnevale V
    'B line' in heart failure: a not so easy issue.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format    



  548. Corrigendum to 'Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart' [Eur J Heart Fail] 2015 August;17(8): 760-763. doi:10.1002/ejhf.315.
    Eur J Heart Fail. 2015;17:1317.
    PubMed     Text format    


  549. VAN DER WAL HH, Cowie MR, van der Meer P
    Sleep-disordered breathing and chronic heart failure: changing position may be important.
    Eur J Heart Fail. 2015;17:1219-22.
    PubMed     Text format    


  550. VESCOVO G
    Neuromuscular junction fragmentation and muscle wasting in heart failure: a sharp cut from a Sica sword?
    Eur J Heart Fail. 2015;17:1216-8.
    PubMed     Text format    


    November 2015
  551. MANN DL, Lee RJ, Coats AJ, Neagoe G, et al
    One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure.
    Eur J Heart Fail. 2015 Nov 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  552. LYON AR, Bossone E, Schneider B, Sechtem U, et al
    Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2015 Nov 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  553. RICHARDS AM, Frampton CM
    Can circulating biomarkers identify heart failure patients at low risk?
    Eur J Heart Fail. 2015 Nov 4. doi: 10.1002.
    PubMed     Text format    


  554. VOLPE M, Santolamazza C, Mastromarino V
    Erythropoiesis-stimulating agents in heart failure: leave it or re-take it?
    Eur J Heart Fail. 2015 Nov 3. doi: 10.1002.
    PubMed     Text format    


    October 2015
  555. STORK S, Kavoliuniene A, Vinereanu D, Ludwig R, et al
    What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative.
    Eur J Heart Fail. 2015 Oct 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  556. EMMENS JE, Ter Maaten JM, Matsue Y, Metra M, et al
    Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
    Eur J Heart Fail. 2015 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  557. SAHLE BW, Owen AJ, Krum H, Reid CM, et al
    Incidence of heart failure in 6083 elderly hypertensive patients: the Second Australian National Blood Pressure Study (ANBP2).
    Eur J Heart Fail. 2015 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  558. DESTA L, Jernberg T, Spaak J, Hofman-Bang C, et al
    Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91 360 patients admitted with index myocardial infarction between 1998 and 2010.
    Eur J Heart Fail. 2015 Oct 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  559. CHAN MM, Santhanakrishnan R, Chong JP, Chen Z, et al
    Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Eur J Heart Fail. 2015 Oct 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  560. D'ELIA E, Vaduganathan M, Gori M, Gavazzi A, et al
    Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.
    Eur J Heart Fail. 2015 Oct 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  561. SANDERS-VAN WIJK S, van Empel V, Davarzani N, Maeder MT, et al
    Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Eur J Heart Fail. 2015 Oct 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  562. GARGANI L
    Prognosis in heart failure: look at the lungs.
    Eur J Heart Fail. 2015 Oct 16. doi: 10.1002.
    PubMed     Text format    


  563. FERRE RM, Chioncel O, Pang PS, Lang RM, et al
    Acute heart failure: the role of focused emergency cardiopulmonary ultrasound in identification and early management.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format    


  564. AMBROSY AP, Hernandez AF, Armstrong PW, Butler J, et al
    The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  565. MELENOVSKY V, Andersen MJ, Andress K, Reddy YN, et al
    Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  566. PINNA GD, Robbi E, La Rovere MT, Taurino AE, et al
    Differential impact of body position on the severity of disordered breathing in heart failure patients with obstructive vs. central sleep apnoea.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  567. PARISSIS J, Farmakis D, Karavidas A, Arapi S, et al
    Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure: practical considerations and proposed algorithm.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format    


  568. MEIJERS WC, de Boer RA, van Veldhuisen DJ, Jaarsma T, et al
    Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  569. PITT B, Bakris GL, Bushinsky DA, Garza D, et al
    Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors.
    Eur J Heart Fail. 2015 Oct 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  570. ASCHAUER S, Kammerlander AA, Zotter-Tufaro C, Ristl R, et al
    The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics.
    Eur J Heart Fail. 2015 Oct 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  571. STEINBECK L, Ebner N, Valentova M, Bekfani T, et al
    Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
    Eur J Heart Fail. 2015 Oct 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  572. KONSTAM MA
    Hyperkalaemia in heart failure: binding the patient to improved treatment?
    Eur J Heart Fail. 2015 Oct 7. doi: 10.1002.
    PubMed     Text format    


  573. VON LUEDER TG, Girerd N, Atar D, Agewall S, et al
    Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
    Eur J Heart Fail. 2015 Oct 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  574. WAGENAAR KP, Broekhuizen BD, Dickstein K, Jaarsma T, et al
    Effectiveness of an interactive platform, and the ESC/HFA heartfailurematters.org website in patients with heart failure: design of the multicentre randomized e-Vita heart failure trial.
    Eur J Heart Fail. 2015 Oct 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  575. BELLO NA, Lewis EF, Desai AS, Anand IS, et al
    Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease.
    Eur J Heart Fail. 2015 Oct 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  576. KRUM H, McMurray JJ, Abraham WT, Dickstein K, et al
    The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics.
    Eur J Heart Fail. 2015;17:1075-83.
    PubMed     Text format     Abstract available


  577. ANSELMINO M, Matta M, Gaita F
    Catheter ablation of atrial fibrillation in patients with heart failure: can we break the vicious circle?
    Eur J Heart Fail. 2015;17:1003-5.
    PubMed     Text format    


    September 2015
  578. BRUNNER-LA ROCCA HP, Eurlings L, Richards AM, Januzzi JL, et al
    Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
    Eur J Heart Fail. 2015 Sep 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  579. TEIXEIRA A, Parenica J, Park JJ, Ishihara S, et al
    Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort.
    Eur J Heart Fail. 2015 Sep 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  580. COIRO S, Rossignol P, Ambrosio G, Carluccio E, et al
    Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure.
    Eur J Heart Fail. 2015 Sep 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  581. BANG C, Antoniades C, Antonopoulos AS, Eriksson U, et al
    Intercellular communication lessons in heart failure.
    Eur J Heart Fail. 2015 Sep 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  582. BRAUNWALD E
    Another step toward personalized care of patients with heart failure.
    Eur J Heart Fail. 2015 Sep 16. doi: 10.1002.
    PubMed     Text format    


  583. KOMAJDA M, Tavazzi L, Francq BG, Bohm M, et al
    Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.
    Eur J Heart Fail. 2015 Sep 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  584. GREENE SJ, Fonarow GC
    Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction?
    Eur J Heart Fail. 2015 Sep 16. doi: 10.1002.
    PubMed     Text format    


  585. SIMPSON J, Castagno D, Doughty RN, Poppe KK, et al
    Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.
    Eur J Heart Fail. 2015 Sep 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  586. OVCHINNIKOVA ES, Schmitter D, Vegter EL, Ter Maaten JM, et al
    Signature of circulating microRNAs in patients with acute heart failure.
    Eur J Heart Fail. 2015 Sep 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  587. XIONG Q, Lau YC, Senoo K, Lane DA, et al
    Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.
    Eur J Heart Fail. 2015 Sep 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  588. MICHAEL FELKER G, Mentz RJ, Teerlink JR, Voors AA, et al
    Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study.
    Eur J Heart Fail. 2015 Sep 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  589. COTTER G, Voors AA, Prescott MF, Felker GM, et al
    Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.
    Eur J Heart Fail. 2015 Sep 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  590. FELKER GM, Ahmad T
    Reclassifying heart failure: time for disruptive innovation?
    Eur J Heart Fail. 2015 Sep 2. doi: 10.1002.
    PubMed     Text format    


    August 2015
  591. LIP GY, Heinzel FR, Gaita F, Juanatey JR, et al
    European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
    Eur J Heart Fail. 2015 Aug 21. doi: 10.1002.
    PubMed     Text format    


  592. PELLICORI P, Clark AL
    Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure.
    Eur J Heart Fail. 2015 Aug 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  593. GREENE SJ, Gheorghiade M
    Same protocol, different continents, different patients: should we continue to conduct global heart failure trials?
    Eur J Heart Fail. 2015 Aug 20. doi: 10.1002.
    PubMed     Text format    


  594. KAO DP, Lewsey JD, Anand IS, Massie BM, et al
    Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
    Eur J Heart Fail. 2015 Aug 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  595. BUTLER J, Gheorghiade M, Kelkar A, Fonarow GC, et al
    In-hospital worsening heart failure.
    Eur J Heart Fail. 2015 Aug 3. doi: 10.1002.
    PubMed     Text format     Abstract available


    July 2015
  596. PLATZ E, Jhund PS, Campbell RT, McMurray JJ, et al
    Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review.
    Eur J Heart Fail. 2015 Jul 31. doi: 10.1002.
    PubMed     Text format     Abstract available


  597. STIENEN S, Salah K, Eurlings LW, Bettencourt P, et al
    Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro a brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
    Eur J Heart Fail. 2015 Jul 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  598. SHIMOKAWA H, Miura M, Nochioka K, Sakata Y, et al
    Heart failure as a general pandemic in Asia.
    Eur J Heart Fail. 2015 Jul 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  599. VAGNARELLI F, Corsini A, Lorenzini M, Pacini D, et al
    Acute heart failure in patients with acute aortic syndrome: pathophysiology and clinical-prognostic implications.
    Eur J Heart Fail. 2015 Jul 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  600. VERBRUGGE FH, Dupont M, Finucan M, Gabi A, et al
    Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure.
    Eur J Heart Fail. 2015 Jul 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  601. FERREIRA JP, Girerd N, Rossignol P, Zannad F, et al
    Geographic differences in heart failure trials.
    Eur J Heart Fail. 2015 Jul 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  602. SCHERBAKOV N, Bauer M, Sandek A, Szabo T, et al
    Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Eur J Heart Fail. 2015 Jul 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  603. LATINI R, Masson S
    Understanding and making good use of changes in natriuretic peptide levels in chronic heart failure.
    Eur J Heart Fail. 2015 Jul 15. doi: 10.1002.
    PubMed     Text format    


  604. SENNI M, Gavazzi A, Gheorghiade M, Butler J, et al
    Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart.
    Eur J Heart Fail. 2015 Jul 15. doi: 10.1002.
    PubMed     Text format    


  605. WOLSK E, Lamberts M, Hansen ML, Blanche P, et al
    Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study.
    Eur J Heart Fail. 2015 Jul 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  606. JAARSMA T, Klompstra L, Ben Gal T, Boyne J, et al
    Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF-Wii study; a multicentre randomized controlled trial.
    Eur J Heart Fail. 2015;17:743-8.
    PubMed     Text format     Abstract available


  607. CANNON JA, Collier TJ, Shen L, Swedberg K, et al
    Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).
    Eur J Heart Fail. 2015;17:707-16.
    PubMed     Text format     Abstract available


  608. LEDWIDGE MT, O'Connell E, Gallagher J, Tilson L, et al
    Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study.
    Eur J Heart Fail. 2015;17:672-9.
    PubMed     Text format     Abstract available


  609. HOTHI SS, Tan LB, Cotter G
    Resting cardiac power index and prediction of prognosis in heart failure.
    Eur J Heart Fail. 2015;17:642-4.
    PubMed     Text format    


    June 2015
  610. MONTERO-PEREZ-BARQUERO M, Formiga F, Manzano L
    About the RICA registry in patients with heart failure.
    Eur J Heart Fail. 2015 Jun 24. doi: 10.1002.
    PubMed     Text format    


  611. HAUPTMAN PJ
    Addressing disparities in heart failure care without borders.
    Eur J Heart Fail. 2015 Jun 17. doi: 10.1002.
    PubMed     Text format    


  612. MENTZ RJ, Metra M, Cotter G, Milo O, et al
    Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial.
    Eur J Heart Fail. 2015 Jun 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  613. FERRARI R, Bohm M, Cleland JG, Paulus WJ, et al
    Heart failure with preserved ejection fraction: uncertainties and dilemmas.
    Eur J Heart Fail. 2015 Jun 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  614. PARISSIS J, Farmakis D, Lekakis J, Filippatos G, et al
    Overcoming the ethnic differences in patients hospitalized for heart failure: is there a need for international harmonization of clinical practice guidelines?
    Eur J Heart Fail. 2015 Jun 4. doi: 10.1002.
    PubMed     Text format    


  615. MEBAZAA A, Longrois D, Metra M, Mueller C, et al
    Agents with vasodilator properties in acute heart failure: how to design successful trials.
    Eur J Heart Fail. 2015 Jun 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  616. PARK JJ, Choi DJ, Yoon CH, Oh IY, et al
    The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean Heart Failure (KorHF) registry.
    Eur J Heart Fail. 2015;17:601-11.
    PubMed     Text format     Abstract available


  617. GRIGIONI F, Senni M
    The Pilot European Survey of Atrial Fibrillation: how to look at heart failure through a keyhole.
    Eur J Heart Fail. 2015;17:541-3.
    PubMed     Text format    


  618. KARPER JC, Westenbrink BD
    BNP in heart failure: even leucocytes cannot escape its influence.
    Eur J Heart Fail. 2015;17:536-8.
    PubMed     Text format    


    May 2015
  619. DONAL E, Lund LH, Oger E, Hage C, et al
    New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Eur J Heart Fail. 2015 May 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  620. DI TANO G, De Maria R, Gonzini L, Aspromonte N, et al
    The 30-day metric in acute heart failure revisited: data from IN-HF Outcome, an Italian nationwide cardiology registry.
    Eur J Heart Fail. 2015 May 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  621. MACDONALD MR, She L, Doenst T, Binkley PF, et al
    Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
    Eur J Heart Fail. 2015 May 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  622. ZILE MR, Abraham WT, Weaver FA, Butter C, et al
    Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy.
    Eur J Heart Fail. 2015 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  623. ANKER SD, Kosiborod M, Zannad F, Pina IL, et al
    Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.
    Eur J Heart Fail. 2015 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  624. ALVAREZ-GARCIA J, Ferrero-Gregori A, Puig T, Vazquez R, et al
    A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients: the Redin-SCORE.
    Eur J Heart Fail. 2015 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  625. HARIKRISHNAN S, Sanjay G, Anees T, Viswanathan S, et al
    Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry.
    Eur J Heart Fail. 2015 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  626. MEBAZAA A, Birhan Yilmaz M, Levy P, Ponikowski P, et al
    Recommendations on pre-hospital & hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emerge
    Eur J Heart Fail. 2015 May 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  627. GOTSMAN I, Avishai-Eliner S, Jabara R, Zemora Z, et al
    Ethnic disparity in the clinical characteristics of patients with heart failure.
    Eur J Heart Fail. 2015 May 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  628. KHAN H, Greene SJ, Fonarow GC, Kalogeropoulos AP, et al
    Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.
    Eur J Heart Fail. 2015 May 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  629. RUGGENENTI P, Remuzzi G
    Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart?
    Eur J Heart Fail. 2015;17:468-71.
    PubMed     Text format    


  630. METRA M
    May 2015 at a glance.
    Eur J Heart Fail. 2015;17:465.
    PubMed     Text format    


  631. HARJOLA VP, Lassus J, Sionis A, Kober L, et al
    Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
    Eur J Heart Fail. 2015;17:501-9.
    PubMed     Text format     Abstract available


    April 2015
  632. SCHMITTER D, Voors AA, van der Harst P
    HFpEF vs. HFrEF: can microRNAs advance the diagnosis?
    Eur J Heart Fail. 2015;17:351-4.
    PubMed     Text format    


  633. METRA M
    April 2015 at a glance.
    Eur J Heart Fail. 2015;17:347.
    PubMed     Text format    


    March 2015
  634. PONIKOWSKI P, Filippatos G, Colet JC, Willenheimer R, et al
    The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.
    Eur J Heart Fail. 2015;17:329-39.
    PubMed     Text format     Abstract available


  635. LAM CS, McEntegart M, Claggett B, Liu J, et al
    Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    Eur J Heart Fail. 2015;17:301-12.
    PubMed     Text format     Abstract available


    January 2015
  636. JOYCE E, Ninaber MK, Katsanos S, Debonnaire P, et al
    Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis.
    Eur J Heart Fail. 2015;17:51-62.
    PubMed     Text format     Abstract available


    December 2014
  637. MAOR E, Grossman Y, Balmor RG, Segel M, et al
    Exercise haemodynamics may unmask the diagnosis of diastolic dysfunction among patients with pulmonary hypertension.
    Eur J Heart Fail. 2014 Dec 8. doi: 10.1002.
    PubMed     Text format     Abstract available


    November 2014
  638. GOUDIE A, Elder D, Deshmukh H, Szwejkowski BR, et al
    Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study.
    Eur J Heart Fail. 2014 Nov 27. doi: 10.1002.
    PubMed     Text format     Abstract available


    September 2014
  639. YU CM, Fang F, Luo XX, Zhang Q, et al
    Long-term follow-up results of the pacing to avoid cardiac enlargement (PACE) trial.
    Eur J Heart Fail. 2014;16:1016-25.
    PubMed     Text format     Abstract available


    April 2014

  640. Abstracts of the 7th Asian Pacific Congress of Heart Failure, 17-19th April 2014, Bali, Indonesia.
    Eur J Heart Fail. 2014;16 Suppl 1:1-41.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: